Ripples of Impact
DEPARTMENT OF PSYCHIATRY ANNUAL REPORT 2026
Ripples of Impact
DEPARTMENT OF PSYCHIATRY ANNUAL REPORT 2026
Ripples of Impact
DEPARTMENT OF PSYCHIATRY ANNUAL REPORT 2026
Ripples of Impact
DEPARTMENT OF PSYCHIATRY ANNUAL REPORT 2026
ACKNOWLEDGEMENTS
This document was written, designed, edited, photographed and produced by the Department of Psychiatry’s Advancement, Communication and Events (ACE) team in 2026. Special thanks to the following people for their contributions in the vision and execution of this document: Claudia Iannelli - design and project management Angel Tran - content and photography Amy Canada - editing Brittany Pittman - editing Patricia Carballo-Cuello - editing Merlin Ariefdjohan - publication management
Special thanks to all the division, center and office directors, administrators and featured faculty who worked with our team to complete interviews and provide all requested information quickly and accurately. We thank you for your collaboration and dedication!
Copyright 2026
CONTENTS Letter from the Chair..............................................................................................................1 2026 Overview........................................................................................................................3 Ripples of Impact: Internal Department.......................................................................................................xx School/University Community.......................................................................................xx Denver Metro Area..........................................................................................................xx State of Colorado.............................................................................................................xx Nationwide.......................................................................................................................xx International.....................................................................................................................xx Publications............................................................................................................................xx Philanthropic giving opportunity.........................................................................................xx 2026 event collages...............................................................................................................xx
RIPPLES OF IMPACT - 2026
A LETTER FROM OUR CHAIR When I reflect on the work of our Department of Psychiatry over the past year, I am struck not only by what we have accomplished, but by the people and partnerships that make those accomplishments possible. Every day, I see faculty, staff, trainees, and community partners bringing their expertise, compassion, and determination together to improve mental health. Often, the impact of that work extends far beyond what any of us could have imagined. That is the inspiration behind this year's annual report, Ripples of Impact. Like ripples spreading across water, our work begins with individual actions and connections that extend outward, reaching patients, families, communities, and colleagues across Colorado and around the world. This year alone, our department touched 114,795 lives, a number that represents extraordinary growth but, more importantly, thousands of individual stories. Some of those stories are especially moving. At Children's Hospital Colorado, our new pediatric electroconvulsive therapy service is giving young people with severe psychiatric conditions renewed opportunities to return to school, reconnect with family, and imagine their futures. Through our Mental Health Transitional Living Homes, individuals who have struggled for years are finding stability and a path toward independence. And through initiatives like PRISM, we are bringing specialized addiction treatment to young people at critical moments in their lives. Our researchers are equally committed to pushing boundaries. Across disciplines, teams are connecting neuroscience, metabolic health, and clinical discovery to explore new approaches to complex psychiatric conditions. These collaborations demonstrate something I believe deeply: our greatest breakthroughs often happen when we bring different perspectives and expertise together.
The ripples extend well beyond our clinical and research settings. The Johnson Depression Center's community programs have now directly reached more than 80,000 people, while VitalCog is empowering individuals across industries to recognize mental health challenges and support those around them. Our partnerships are helping translate academic expertise into practical tools that strengthen communities. I am also particularly proud of the ways we are investing in our own people. From expanding opportunities for Masters Licensed Therapists to advance in academic medicine to developing the next generation of social workers and creating spaces for employees to share their experiences, we are recognizing that our ability to care for others begins with supporting one another. What I hope you take from these pages is that none of this happens in isolation. A researcher mentors a trainee. A clinician helps a family find hope. A community member uses something learned in a training to support a colleague. Each connection creates the possibility for another. As we look ahead, I am energized by what we can accomplish together. Thank you to everyone who contributes to this remarkable department. Your dedication is shaping the future of mental health care, and the ripples of your impact will continue to reach farther than we may ever know.
Neill Epperson, MD Robert Freedman Endowed Chair and Professor
Our greatest breakthroughs often happen when we bring different perspectives and expertise together.
2026 DEPARTMENT IMPACT
THE TEAM BEHIND OUR IMPACT
XXX
TOTAL EMPLOYEES IN 2026
448
TOTAL TRAINEES IN 2026
*Including all graduate and undergraduate medical education programs
OPERATING BUDGET
141,093,322
114,795 TOTAL LIVES TOUCHED
The Department of Psychiatry has engaged in collecting information on “lives touched” since 2018. A “life touched” is an individual who has received a service or gained in some way from interacting with the Department.
685%
74,674 UNIQUE CLINICAL PATIENTS
INCREASE IN LIVES TOUCHED SINCE 2018
RESEARCH + DISCOVERY
253
$29,144,105
PEER-REVIEWED PUBLICATIONS
GRANTS & CONTRACTS IN 2025
317 ACTIVE STUDIES
CURRENT BLUE RIDGE RANKING
XXX
APPROVED STUDIES CURRENT FEDERAL GRANTS
*Lives Touched figures represent FY26 running from July 1, 2025 through June 30, 2026.
21
RIPPLES OF IMPACT - 2026
LISTENING TOGETHER. GROWING STRONGER. REACH: DEPARTMENT
SHAPING THE PATH TO WELL-BEING Written By Liz Chamberlain
The DOPsych Wellness team has been working across Department Divisions to support both Faculty and Staff in 2026 - we continued shaping our path to well-being this past year by measuring how we're doing and connecting feedback to action. We collected wellness survey data for Faculty (as part of the School of Medicine's bi-annual initiative) and adapted the survey for Staff to learn how we're doing, what's going well, and what we can improve.
7.69
7.34
2024: Gold 2025: Gray
6.5
Collegiality
7.24
7.56
6.64
Belonging
Meaning in Work
For Faculty, we noted improvements in Belonging, Collegiality, and Meaning in Work since the 2024 survey.
In addition, 74% of Staff reported feeling supported by their immediate supervisor, another key indicator of belonging at work and a buffer for burnout.
3.39
3.42
Cutoff = 3
For Staff, we learned we are doing better than the benchmark score (Stanford Professional Fulfillment Inventory) in Professional Fulfillment and Belonging, both of which serve as buffers for workplace burnout.
Based on the data, we have prioritized several areas that are meaningful to Faculty and Staff, including more mentorship opportunities, increased peer support, and improved communication about compensation. Each of these priorities are incorporated into the Department’s wellness action plan for this academic year.
THREE PRIORITIES. ONE HEALTHIER WORKPLACE. More mentorship opportunities. Increased peer support. Improved communication about compensation. All informed by employee feedback and incorporated into the department's wellness action plan.
RIPPLES OF IMPACT - 2026
REACH: DEPARTMENT
LISTENING, LEARNING AND BUILDING CONNECTION ITY - PATH N TU
This year, the Opportunities, Pathways, Engagement
W
GA
GE
OR
-EN
K
AYS W
OPPO R
Written By Shaleeta Flagg
MENT - N
ET
and Network (OPEN) team focused on creating opportunities to connect more with faculty and staff, better understand their experiences, and identify meaningful ways to strengthen engagement and support across the Department of Psychiatry. An example of this work was the ARTS Listening Tour, which was conducted from January through July 2026. We wanted to build connections and have
a direct conversation about what our ARTS employees needed. The initiative created opportunities to meet staff where they work, hear directly about their experiences, and better understand opportunities and challenges affecting teams. The listening tour reached six ARTS locations and engaged 76 employees through conversations with faculty and staff. Visits included Potomac Street Center, Westside Center for Change, East Side Specialized Clinic, Parkside Clinic, Gratitude House for Men, and Lighthouse for Women. From these conversations, several themes were identified, including staff support, employee well-being and mental health resources, awareness of employee resources, and the importance of continued opportunities for connection and engagement.
Meaningful engagement doesn't always require launching a new program. Sometimes it begins with creating space to listen and connect.
The visits didn’t end with listening. A volunteer opportunity was identified from these visits that brought together 16 volunteers, providing a way for employees across the department to connect with one another.The work reinforced an important lesson for OPEN: meaningful engagement does not always require launching a new program. Sometimes it begins with creating space to listen and connect employees. As OPEN moves forward, the lessons learned will help inform us how we continue to engage employees and interpret feedback into practical action. The aim is to build an ongoing approach in which employees have opportunities to share their perspectives, understand what happens with their feedback, and remain connected to the broader work of the department.
Volunteers worked to organize clothing donations for our the ARTS locations. Shaleeta Flagg
REACH: SCHOOL OF MEDICINE
CONNECTING EXPERTISE TO ACCELERATE MENTAL HEALTH DISCOVERIES Written by Amanda Law and Stephanie Vetter
Collaboration across divisions, departments, and institutions connects expertise throughout the CU Anschutz Department of Psychiatry, advancing research, strengthening mentorship, and creating opportunities to improve mental health care. Dr. Sharon Hunter’s collaborations span adult psychiatry, developmental research, obstetrics, neonatology, and anesthesiology. She works with Dr. Epperson on adult EEG research and mentors Danielle Swales through a K award, with plans to extend their work to infant and child data. As principal investigator of an infant MRI R01, Dr. Hunter collaborates with Dr. Camille Hoffman in OB-GYN, neonatologist Erica Wymore, and anesthesiology researchers Cristina Sempio and Jost Klawitter. She also mentors Devika Bhatia in clinical trials and longitudinal research. Manuscripts underway connect her with former psychiatry resident Alankrita Zutshi, medical students, and researchers Jason Tregellas, Kristina Legget, and Anika Guha across the Divisions of Neuroscience and Addiction Science.
Dr. Kristina Legget and Dr. Chris Schneck are adding neuroimaging to the Child Bipolar Network’s multisite trial investigating a ketogenic diet for adolescents with bipolar disorder. Supported by a philanthropic donation, this pilot uses functional MRI and magnetic resonance spectroscopy to explore neurobiological changes associated with a 16-week ketogenic diet. The team is working with investigators at UCLA, the University of Cincinnati School of Medicine, and the University of Pittsburgh Medical Center, aiming for 10–20 participants to complete neuroimaging across the four sites.
Dr. Legget’s VA-funded trial examines how exercise affects stress-related eating and associated neurobiology in Veterans with overweight or obesity. Collaborators include Dr. Liz Thomas and Dr. Ed Melanson from the School of Medicine’s Division of Endocrinology, Metabolism and Diabetes, alongside Dr. Tregellas and Dr. Susan Mikulich. Their combined expertise connects metabolic health, behavior, and neuroscience. Dr. Jason Tregellas’s VA Merit study similarly bridges psychiatry and metabolic research, investigating whether GLP-1 agonists may improve cognition in schizophrenia alongside metabolic outcomes. Dr. Andrew Novick serves as study physician, with Drs. Legget, Mikulich, and Jane Reusch contributing as coinvestigators. Dr. Reusch brings expertise from the Department of Medicine’s Division of Endocrinology, Metabolism and Diabetes. Dr. Tracy Bale’s collaborations explore biological markers of stress and treatment response. With Dr. Steve Berkowitz, she is identifying markers of healthy stress responses to better understand trauma’s biological effects. She also works with Dr. Novick to investigate plasma markers of response to psilocybin treatment for depression and with Dr. Joe Schacht to identify treatment-response markers in a GLP-1 clinical trial for alcohol use disorder. Dr. Scott Thompson’s preclinical research helped inform Dr. Novick’s trial of psilocybin for treatment-resistant depression. Thompson studies whether psilocybin can reverse stress-related deficits in reward behavior in mice, a model of anhedonia. These findings encouraged Novick to examine anhedonia in his placebocontrolled trial, which found greater symptom reductions among participants receiving psilocybin. A manuscript is under review.
Dr. Amanda J. Law also builds interdepartmental connections across the School of Medicine, including jointly mentoring DPRG postdoctoral fellow Chad Camp with Dr. Tim Benke from the Department of Pharmacology. Together, these collaborations demonstrate how shared expertise links laboratory discoveries, clinical investigation, and the development of future researchers.
REACH: SCHOOL OF MEDICINE
A SEAT AT THE TABLE: MASTERS LICENSED THERAPISTS EXPAND THEIR ROLE IN ACADEMIC MEDICINE Written By Angel Tran with Support from Emily Hemendinger, Mandy Doria and Laura Anthony
For many years, academic medicine has been a space traditionally associated with physicians, psychologists, and other doctoral-level professionals. However, within the University of Colorado Department of Psychiatry, Masters Licensed Therapists (MLTs) are demonstrating that meaningful contributions to clinical care, research, education, and leadership are not defined solely by academic degrees. These include people who have LCSW (licensed clinical social worker), LPC (licensed professional counselor), LMFT (licensed marriage and family therapist), and LAC (licensed addictions counselor) licenses. As the Department continues to grow, so does the presence and influence of MLTs. The recent adoption of the Masters Licensed Therapist designation brings greater clarity to their professional roles while recognizing the expertise they contribute to the Department's missions. What started as a handful of therapists has grown into a workforce of nearly 100 providers (and keeps growing!). The Department of Psychiatry is proud to have amazing therapists who can work with our psychiatry, psychology, and nurse practitioner providers. Historically, uncertainty surrounding degree requirements and promotion eligibility made it difficult for some master's-level clinicians to envision advancement within academic medicine. Over time, MLT faculty have challenged these assumptions by teaching, publishing, conducting research, developing programs, and assuming leadership responsibilities. Importantly, MLTs can pursue faculty promotion, and all faculty are evaluated using the same criteria regardless of degree. Promotion is a collaborative process involving faculty, mentors, and Department leadership, with conversations focused on professional goals, mentorship, career development, and alignment with School of Medicine priorities.
The Department follows School of Medicine promotion guidelines, with recent efforts providing greater clarity around terminal degrees and advancement to Senior Instructor or Assistant Professor. Faculty scholarship also extends well beyond traditional research. Teaching, conference presentations, publications, patient education materials, program development, and policy improvements are among the many ways MLTs can demonstrate their contributions. The growing presence of MLTs in academic and leadership roles represents more than individual career advancement. It reflects an evolution in how expertise is recognized, whose perspectives shape decisions, and what is possible for master's-level clinicians. “Our academic MLTs are multidimensional in skill sets, incredible problem solvers, and overall well-rounded humans that care about other humans. They have a history of having one of the most undervalued, difficult jobs in mental health, while also having a huge impact on a wide range of outcomes for patients and trainees,” says Mandy Doria, Associate Professor in the Department of Psychiatry. For MLTs, having a seat at the table is no longer simply about participating in the conversation. It's about helping lead it, shaping the future of academic medicine, and creating opportunities for the next generation of therapists.
Mandy Doria, MS, LPC
Emily Hemendinger, LCSW, MPH
“My advice to any MLT who is
“I’m extremely grateful that the Department
considering promotion is to first, do what
has allowed MLTs to be part of the promotions
you love, and then, see if that falls within
process and hold leadership positions. I’m
the scope of impact and achievement
someone who is passionate about clinical care
that the SOM considers as being qualified
AND so many other things, such as advocacy,
for Assistant Professor. It's important to
scholarship, writing, and teaching. Working in
collect data points of everything you are
academia has allowed me to engage with
doing because it matters and you deserve
those passions in ways I would’ve never
the recognition!”
thought possible for an MLT.”
RIPPLES OF IMPACT - 2026
REACH: UNIVERSITY
BELONGING BY DESIGN: CREATING STRONGER WORKPLACE CULTURES THROUGH CONNECTION AND COLLABORATION Written By Amy Canada
The summit brought together faculty, staff, students, and system administration leaders to explore strategies that strengthen belonging, meaningful work, and well-being across the CU system. Through scenario-based activities, discussion, and collaborative learning, participants examined how psychological safety serves as a foundation for trust, innovation, engagement, and team effectiveness. Attendees explored practical approaches October 2, members of the Department of Psychiatry Shaleeta Flagg, Shanna Trott, and Amy Canada along with Lamar Cherry from the SOM Md Program presented an interactive session, Belonging by Design: From Psychological Safety to Collective Creation, at the CU Inclusive Excellence Summit on the CU Denver campus. Their session engaged faculty and staff from all four University of Colorado campuses in meaningful dialogue about creating workplace cultures where individuals feel valued, respected, and empowered to contribute their perspectives.
for fostering inclusion and creating environments where every voice can contribute to shared success.
4 CU CAMPUSES. ONE SHARED COMMITMENT. Faculty and staff came together to explore how psychological safety strengthens trust, collaboration, and belonging.
The presentation’s impact extended beyond the session itself by equipping participants with actionable tools to strengthen belonging within their own departments and teams. By challenging attendees to move from individual awareness to collective action, the presenters inspired participants to intentionally design cultures that support collaboration, encourage diverse perspectives, and enhance employee engagement. The session reinforced the university’s commitment to inclusive excellence and helped advance systemwide efforts to create a community where all individuals can thrive, contribute, and succeed.
RIPPLES OF IMPACT - 2026
LOCAL CONNECTIONS. LASTING IMPACT.
REACH: DENVER METRO
BUILDING PATHWAYS TO RECOVERY AT FORT LOGAN Written By Trevor Manley
Founded in 1972, Addiction Research and Treatment Services (ARTS), a clinical program within the University of Colorado Department of Psychiatry, has helped individuals and families across Colorado overcome substance use disorders through evidence-based treatment, recovery services, and compassionate care. Today, ARTS is building on that legacy through transformative investments at the Fort Logan campus that expand access to care, strengthen recovery supports, and address critical community needs. Recovery does not end when treatment is complete. Long-term success often depends on safe housing, supportive relationships, and continued access to care. Recognizing these needs, ARTS is leveraging opioid settlement funding awarded by the Colorado Department of Law, Division of Community Engagement to expand recovery housing and support services for individuals experiencing opioid and other substance use disorders who face housing instability. The funding will strengthen ARTS' Level 3 Recovery Homes, including Gratitude House for men and Lighthouse for women, pregnant women, and women with dependent children. Residents will have access to a range of recovery supports, including peer counseling, case management, transportation assistance, employment services, family-centered resources, and connections to community programs. Together, these services help individuals navigate the challenges of early recovery while building the stability and support networks that promote long-term success. By investing in recovery housing, ARTS is expanding access to resources and supports associated with stronger long-term recovery outcomes.
At the same time, utilizing Colorado Opioid Abatement Council Infrastructure Funding, granted through the Colorado Attorney General’s Office, ARTS is creating a new chapter for Fort Logan through the development of the Princeton Clinic, a new outpatient treatment center designed to increase access to comprehensive behavioral healthcare in southwest Denver. The clinic will offer outpatient and intensive outpatient services, medicationassisted treatment, and integrated care for individuals experiencing both substance use and mental health disorders. The need for these services is significant. Denver, Arapahoe, and Jefferson Counties continue to experience some of the highest rates of opioid-related overdose deaths in Colorado. Communities surrounding Fort Logan, including Sheridan, Lakewood, and Littleton, face ongoing behavioral health challenges, including substance use and homelessness. Sheridan is recognized as a medically underserved community where access to integrated behavioral healthcare is especially important. The Princeton Clinic will address a significant service gap by providing outpatient, intensive outpatient, medication-assisted treatment, and integrated behavioral health services in an area where few providers offer this full continuum of care. The clinic will also strengthen the continuum of care available to residents living in ARTS recovery housing, allowing them to access treatment and recovery supports close to home. The project further expands opportunities for collaboration with community healthcare partners, including Sheridan Health Services, which serves approximately 3,200 patients annually at its Fort Logan location. Together, these organizations will help connect patients to behavioral health, primary care, and recovery services, increasing access to comprehensive care within the community. Through expanded recovery housing and the development of the Princeton Clinic, ARTS is investing in both recovery and community well-being. These initiatives reflect a commitment to meeting people where they are, addressing gaps in care, and building pathways to recovery that extend beyond treatment. By strengthening access to housing, healthcare, and support services, ARTS is helping individuals and families build healthier futures while strengthening Colorado communities.
RIPPLES OF IMPACT - 2026
SHARED KNOWLEDGE. FORWARD MOTION. REACH: DENVER METRO
BRIDGING THE GAP: GROWING THE MENTAL HEALTH WORKFORCE Written By Amy Lopez
One of the primary barriers for students who graduate with degrees in mental health is receiving the clinical supervision that will lead them to licensure. After graduation, independent licensure generally requires a minimum of two years of direct practice and weekly clinical supervision. Licensure supervision is not always provided as part of employment, or may be primarily administrative in nature, leading social workers to either not receive their license, which limits their abilities to provide mental health care, or to pay out of pocket for clinical supervision. Clinical supervision is not only required for licensure but is also a vital part of trainees’ hands-on learning and professional development. To bridge the gap between graduate social work education and licensed, independent practice, in 2021, the Adult Division launched Social Work Fellowship program. This Fellowship is similar to other post-schooling training that psychiatry residents, psychologists, and mental health nurse practitioners complete, and is designed to address barriers to workforce development during the critical period between graduation and licensure. Their training includes hands-on clinical experience, educational lectures with subject matter experts, supervision with licensed therapists, and career development moving toward professional positions. The Child Division has had a similar program since 2015.
In addition to career development for therapists, this program fills a gap in patient care. The Social Work Fellows conduct approximately 2500 therapy visits a year, work in the IOP programs, and have reduced or eliminated wait lists in the outpatient clinics. The program in the adult division has had 17 Fellows since 2021, 9 of whom have completed the program with their LCSW; the other 8 are currently in progress of completing their clinical hours. Of the 9 who completed the program with their LCSW, 6 of them were hired as faculty by the DOP. The other 3 work in private practice groups in the community. All 9 who have completed continue to work in the mental health field, caring for patients. In the Child Division, there have been 23 people complete the program with an LCSW or an LPC. Of those, 78% remained at Children’s Hospital as employees. This program has provided a pathway to help grow the mental health workforce and has been a benefit to the employee and providers. Initial outcomes of the Fellowship program show that the program is gaining more interest. The number of applicants has grown from six applicants in 2021 and 21 applicants in 2026, with interest from across the entire country. This program has become desirable to students around the country a way to both gain clinical licensure while also receiving robust, multi-disciplinary training.
By connecting emerging therapists with clinical training and supervision, the fellowship builds a path to licensure while expanding access to patient care. Amy Lopez, LCWS
REACH: DENVER METRO
FROM RESIDENCY TO COMMUNITY IMPACT: TRAINING PSYCHIATRISTS TO EXPAND ACCESS TO CARE Written By Helena Winston
In 2023, the University of Colorado School of Medicine Psychiatry Residency launched its Community & Public Psychiatry Track (CommPPT) to develop the skills and interests of residents passionate about serving the general public, and especially those with severe mental illness, in either direct patient care or indirect leadership or administrative public psychiatry positions post-graduation. The track has been a major draw for applicants, with approximately 260 applying each year for two open positions. The track, designed by Dr. Helena Winston, helps those residents who are motivated to care for underserved populations to have more exposure to caring for these patient populations and develop an increased understanding of the socioeconomic and political factors that affect them. The goal is to train psychiatrists who will make an impact on a local and national level. Ultimately, the track hopes to motivate residents to take positions that accept Medicare/Medicaid, despite reimbursement difficulties, in order to provide high-level excellent care to those most in need in an era of severe psychiatrist shortages.
CommPPT begins in the second year of residency. During this year, residents start additional didactics (2 hours every other week) that cover topics such as advocacy, systems-based care, treatment of first-episode psychosis, assertive community treatment programs, and value in psychiatric interventions and programs. They complete an extra month of addiction training and also begin site visits to various locations all over the state, including the state hospital and harm reduction centers. Most rotations are completed at Denver Health. Residents also begin their Denver Health continuity clinic in the second year, which continues into the third year. Third-year is a continuation of didactics, continuity clinic, and work in an integrated behavioral health clinic as well as a community mental health center clinic (3rd or 4th year). Fourth-year residents are Community & Public Psychiatry chiefs, assisting with scheduling and some didactic development as well as often serving as Chiefs at Denver Health. Signs of CommPPT success include academic scholarship: CommPPT residents have presented multiple posters at the annual meeting of the American Psychiatric Association and the (now defunct) APA Mental Health Services meeting. CommPPT graduated its first two residents in 2026, William Bomar and Elizabeth Mause. Dr. Bomar is currently a Consultation-Liaison fellow and Dr. Mause is a Forensics fellow, both at the University of Colorado. CommPPT is directed by Helena Winston, MD
RIPPLES OF IMPACT - 2026
REACH: COLORADO
mindLAMP: Scaling Digital Mental Health Innovation Written By Allison Dempsey
BBICen is advancing the implementation and evaluation of mindLAMP, an open-source digital mental health platform developed by our collaborators at Beth Israel Deaconess Medical Center. Through this partnership, our focus is not simply on the technology itself, but on developing scalable models for integrating digital mental health innovations into large health systems. Over the past year, BBICen has incorporated mindLAMP into the development of a digital mental health clinic model that combines patient monitoring, measurement-based care, digital interventions, and clinician support workflows. We are also building a digital navigator program designed to help patients and providers effectively adopt mental health technologies. While initially leveraging mindLAMP, this infrastructure will support a broader portfolio of digital tools and create a sustainable pathway for bringing evidencebased innovations into routine clinical care. Looking ahead, BBICen will examine how mindLAMP and related technologies can facilitate implementation of Collaborative Care and other evidence-based behavioral health models. Ongoing work includes a perinatal mental health study evaluating technology-enabled approaches to monitoring and intervention in pregnant and postpartum populations. We are also pursuing a precision medicine framework by identifying which digital intervention components are most effective for specific patients, examining mechanisms of change, and investigating digital biomarkers that may predict treatment response. Together, these efforts aim to improve access, personalize care, and establish scalable implementation models that accelerate the adoption of digital mental health innovations across health systems.
REACH: COLORADO
A Place to Heal: Helping Individuals Find Stability and Reclaim Their Lives Written By Kamleh Shaban
The Mental Health Transitional Living Homes have had a fabulous year in the community. The MHTL program serves individual with severe mental illness providing a safe transitional living environment for those needing stronger supports but not meeting criteria for inpatient hospitalization. With a total of 17 homes across three levels of care, the MHTL program has provided care to 289 individuals (year to date 2026). MHTL homes provide a level of stability for those who have spent a large portion of their lives stuck in a cycle of hospitalization or incarceration. Our referrals come from diverse settings, including inpatient hospitalizations (allowing people to safely step down into the community) or outpatient care centers (allowing people to step up into a stabilizing environment, possibly preventing another hospitalization). We have helped people reach a level of psychiatric stability many have never experienced in their lives.
14 Months to a New Beginning After 14 months of individualized support, a client whose severe OCD and anxiety once made daily life nearly impossible was able to return home and live successfully.
Our greatest success is hearing from patients, families, and other care coordinators about how well their loved ones look and feel. As the medical director, I’m honored to see the lives we’ve touched and the help we provide. Our staff work with patients, families, and other support systems to help people get back on their feet. Our team frequently receives encouraging feedback, but one 14 month journey truly highlights our mission. When this client first arrived, severe OCD and anxiety made basic daily tasks impossible. His parents felt caring for him at home was no longer feasible. Staff worked with the client and his family, establishing an effective medication routine, teaching symptom management, and restoring his personal routines. He ultimately was able to return home and live successfully.
RIPPLES OF IMPACT - 2026
REACH: COLORADO
CoBE x CU Psych Learning Written By Michael Kazanjian and Holly Ables
Stronger mental health care starts with connection: between patients and healthcare providers, between research and practice, and between university expertise and community needs. Combining the Colorado Bipolar Education Project (CoBE) with the CU Psych Learning platform opens an exciting opportunity to strengthen those connections across Colorado and beyond. The CU Psych Learning platform ensures accessible, anytime/anywhere access to CoBE’s free, four-course, APA-accredited series. Bipolar Disorder in Practice: A Rapid, EvidenceBased Guide for Therapists supports therapists and other healthcare providers with practical, research-based tools for everyday patient care. Brief, engaging, narrated video lessons focus on topics including Family Focused Therapy, Interpersonal and Social Rhythm Therapy, Sleep and Bipolar Disorder, and Cognitive Behavioral Therapy for Bipolar Disorder. Courses include downloadable materials to support clinical care and to share with patients.
Leading this work are Christopher Schneck, MD and Aimee Sullivan, PhD of the CU Anschutz Department of Psychiatry (pictured below). With over 25 years of experience researching and treating bipolar disorder, Dr. Schneck, the Executive Director and Medical Director of the Johnson Depression Center, brings deep clinical expertise. Dr. Sullivan, Assistant Professor, contributes more than 15 years of clinical and research experience and a decade of training community providers.
Together, and with generous donor support, they are sharing their knowledge with a clear purpose: helping providers build the skills and confidence to assess, treat, and support people living with bipolar disorder. Their work advances the spirit of “Psychiatry Connection,” leading together toward more informed, compassionate care, and greater understanding of mental health.
The CoBE and CU Psych Learning teams are connecting university expertise with community needs, helping providers build the skills and confidence to support people living with bipolar disorder.
RIPPLES OF IMPACT - 2026
REACH: COLORADO
The Behavioral Health and Wellness Program: Regional Networks for Comprehensive Tobacco Treatment Written By Robyn Hacker and Derek Noland
The Behavioral Health and Wellness Program (BHWP) is a center of excellence for public policy, research, and clinical care. It connects professionals and peers throughout the United States to an expansive catalogue of trainings to improve the mental health landscape. BHWP’s whole-health offerings include curriculums on motivational interviewing, deescalation, and trauma-informed care, but BHWP is best known for driving health systems change and helping others treat nicotine and tobacco use disorders across the lifespan. Over the past 3 years, BHWP connected organizations in rural parts of Colorado to build selfsustaining regional networks focused on the prevention and treatment of nicotine use. BHWP worked in different regions each year of the project – San Luis Valley, Northeast Colorado, and the West Mountain Region – and recruited diverse organizations to participate (e.g., hospitals, behavioral health, public health, peer, school and youth-serving organizations, etc.). To kick off the Regional Network each year, BHWP traveled to the region and convened an inperson Action Forum to which all participating organizations sent representatives. The Action Forums facilitated connection building, collaboration, knowledge acquisition, and goal setting. BHWP team members provided didactic information and reviewed regional nicotine data to support the goal of decreasing nicotine/tobacco use within each region.
By the conclusion of each Action Forum, the regional partners co-created overarching goals for the region and selected individual organizational goals to support them. Throughout the project, BHWP provided technical assistance, ongoing education, and free training opportunities to facilitate continued relationship building and knowledge attainment within the region. To accommodate the preferences of each region, BHWP facilitated community calls at their desired frequency to support goal completion and collaboration and developed regionally tailored webinars. Each participating organization also had access to free training opportunities to improve nicotine/tobacco knowledge and cessation skills throughout the region. To conclude the project each year, BHWP returned to the region to convene an in-person Sustainability Meeting. This final meeting was designed to support continued connection building and collaboration and to facilitate the smooth transition from BHWP leadership to the region. Members of the Regional Network chose new names and geographical boundaries to expand the work; steering committees were formed to ensure the sustainability of the group, and upcoming meetings were scheduled. Through the three years of this project, 29 different organizations representing over 20 counties participated. Thirty-three people took advantage of the free training opportunities, and 10 people completed training to become Tobacco Treatment Specialists. The project led to increased referrals to the Colorado QuitLine, systems level education efforts, implementation of Opt Out screening and referral protocols, the development of clinical groups focused on nicotine cessation within diverse delivery settings, electronic medical record updates to support nicotine cessation, and increased access to nicotine treatment medications. While these tobacco specific outcomes impressively improved Colorado’s mental health landscape, another rewarding outcome was revealed in the data gathered. Participating organizations’ selfassessed inter-site partnership and collaboration improved as assessed using the Partnership Assessment Tool for Health (PATH). Most encouraging of all, the Regional Networks continue to meet regularly to address nicotine use, in some regions even years after the project’s conclusion.
Jim Pavlik, Senior Program & Policy Analyst Dr. Robyn Hacker, Assistant Professor Derek Noland, Community Liaison
REACH: COLORADO
UNIVERSITY OF COLORADO FUNCTIONAL NEUROLOGIC DISORDER (FND) CLINIC EXPANDS SERVICES AND PATIENT REACH Written By Randi Libbon
Seizure (NES) Clinic, founded by Drs. Laura Strom and Alison Heru through a collaboration between neurology and psychiatry. Initially focused on functional seizures, the clinic developed an innovative, multidisciplinary treatment model combining neurological assessment, behavioral health evaluation, 12 weeks of group therapy, and coordination with community providers. Recognizing the need to serve a broader Functional Neurological Disorder (FND) is a complex condition in which patients experience symptoms resembling neurological disorders such as seizures, strokes, or multiple sclerosis, without the structural abnormalities typically associated with those conditions. Often misunderstood and historically stigmatized, FND involves disruptions in how brain networks function and communicate. For patients navigating this challenging diagnosis, access to
population, the program expanded in 2025 to include patients with functional movement disorders (FMD), the second most common FND subtype. Supported primarily through Upper Payment Limit (UPL) funding, the expansion brought four additional team members, including expertise in movement disorders, rehabilitation, behavioral health, and patient navigation. What began as a small clinic has grown into a multidisciplinary team of 14 professionals.
specialized, compassionate care can be life-changing.
14 Clinics. 40+ Specialists.
The University of Colorado's FND program began in 2016 as the Non-Epileptic
Building a statewide network of rehabilitation expertise for FND treatment.
The program's growth has significantly
These partnerships are particularly
increased access to specialized care. Before expansion, the clinic served approximately 400–500 patients annually. Over the past 15 months, it received 191 referrals for primary FMD, accepting approximately 90% into treatment.
important for patients with FND, who frequently experience additional medical and psychiatric conditions and may have encountered stigma or misunderstanding in previous healthcare settings. By connecting neurology, psychiatry, rehabilitation, and community providers, the program offers coordinated, comprehensive care tailored to patients' complex needs.
Collaboration has been central to this progress. The program partnered with the Movement Disorders section of neurology, including section chief Dr. Amy Amara, to broaden its clinical capabilities. It also established partnerships with 14 UCHealth rehabilitation clinics, training more than 40 physical, occupational, and speech therapy specialists across Colorado to deliver evidence-based motor retraining treatments.
Looking ahead, the team hopes to establish a Center of Excellence for FND, expanding treatment to all FND subtypes through sustainable funding and continued collaboration. Building on nearly a decade of specialized care, the program is creating new pathways to treatment for patients who have too often struggled to find the support they need.
FND team represents CU at the Functional Neurologic Disorder Conference in Baltimore, June 2026
ONE VISIT. MORE CONNECTED CARE. REACH: COLORADO
THE JOURNEY INTO PEDIATRIC PRIMARY CARE Written By Sandra L. Fritsch and Melissa Buchholz
Anxiety disorders are more common in childhood than asthma, but many primary care providers have more expertise in assessing and treating asthma than mild to moderate behavioral health concerns. The Department of Psychiatry at CU SOM has worked to support primary care providers throughout Colorado through mental health access programs such as CoPPCAP, EASY, and PROSPER; supporting our family medicine colleagues with their integrated behavioral health initiatives; HealthySteps, and programs such as CLIMB offered in the Child Health Clinic, Young Mother’s and Families Clinic and Special Care Clinic at Children’s Hospital Colorado. Yet pediatric primary care providers continue to experience the profound challenges of finding access to mental health care treatments due to workforce shortage challenges. Children’s Hospital Colorado’s (CHCO) Pediatric Care Network (PCN), a Clinically Integrated Network, supports independent pediatric primary care practices through Value-Based Care initiatives, care coordination services, and other supports. Work began in 2024 to identify practices in the PCN interested in participating in a pilot program to design and provide a multi-tiered approach to implementing mental health universal screening, prevention and promotion, Integrated Behavioral Health, and the Collaborative Care Model (CoCM). Early adopter practices from the PCN and CHCO signed on to participate in the pilot program, and integrated service delivery with embedded master’s level licensed behavioral health clinicians and child and adolescent consulting psychiatrists began in March 2026.
Through screening for behavioral health concerns at routine visits to warm handoffs available to support primary care providers with addressing behavioral health needs of their patients, youth and families are now being assessed and receiving brief evidence-based interventions in the pediatric primary care setting. When care needs exceed the role of service in the primary care setting, care coordination services identify and support referrals to community providers. This program will continue to grow with offerings to specific clinics at Children’s Hospital Colorado and throughout the state owing to the success and continued needs. In collaboration with community pediatric providers, multidisciplinary care team members, family and youth partners, and national experts from Spark Networked Improvement, planning is underway for the design and launch of a first-of-its-kind Integrated Primary Care Network (IPCN), a learning health network focused on accelerating the adoption of mental health integration in pediatric primary care which results in better access to mental health care for youth and families. Learning health networks bring patients and families, clinicians, researchers, and health systems together around a common aim; measure outcomes across many sites; learn from variation; and turn what they learn into better care.
On 10/26/26, the Behavioral Health Administration (BHA) announced, in partnership with the University of Colorado Anschutz, Valley-Wide, Zero Overdose and Children’s Hospital Colorado, that they have officially received a federal grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) for pediatric behavioral health support and screening. The grant, titled Colorado Integrated Care Project (CICP), falls under the Promoting the Integration of Primary and Behavioral Health Care (PIPBHC) program and provides up to $10 million over a five-year period through 2031.
REACH: COLORADO
EXPANDING PSYCHIATRIC NEUROTHERAPEUTICS AND PRECISION NEUROMODULATION Written By Rachel Davis
The Department of Psychiatry’s Adult Division is expanding access to innovative treatments for psychiatric disorders through the growth of its neuromodulation services, the establishment of a new Psychiatric Neurotherapeutics Clinic (PNC), and the recruitment of nationally recognized expertise in precision neuromodulation. Together, these developments strengthen the department's ability to provide advanced clinical care while integrating neuroscience research with the development of more effective, individualized treatments.
Expanding Access to Psychiatric Neurotherapeutics A major development this year is the establishment of the Psychiatric Neurotherapeutics Clinic (PNC), a dedicated outpatient clinic located on Colfax Avenue, directly across from UCHealth University of Colorado Hospital. The clinic will initially focus on intranasal esketamine (Spravato), an FDA-approved treatment for adults with treatment-resistant depression. The new clinic represents an important investment in improving access to interventional psychiatric treatments. Planned renovations will allow the PNC to expand its treatment capacity and serve more patients, helping address growing demand for these services. The department also plans to introduce intravenous (IV) ketamine for major depressive disorder in the future, further broadening treatment options for patients who have not responded adequately to conventional approaches.
The PNC will complement the department's existing neuromodulation programs, which offer transcranial magnetic stimulation (TMS) for major depressive disorder and obsessivecompulsive disorder (OCD), electroconvulsive therapy (ECT), esketamine, and deep brain stimulation (DBS) for OCD and other psychiatric indications. The department also anticipates introducing vagus nerve stimulation (VNS), adding another treatment option for patients with difficult-to-treat psychiatric conditions. Together, these services provide a broad spectrum of treatment options for patients with complex and treatment-resistant psychiatric disorders, with an emphasis on expanding access to individualized care.
Expanding Access to Psychiatric Neurotherapeutics
The department welcomed Desmond Oathes, PhD, as Professor of Psychiatry, Executive Director of Precision Neuromodulation in Psychiatry, and Research Director for the Adult Division. Dr. Oathes joins CU Anschutz from the University of Pennsylvania, where he directed the Penn Center for Brain Imaging and Stimulation and held leadership roles in interdisciplinary neuroscience and neuromodulation programs. A clinical psychologist and neuroscientist, Dr. Oathes brings extensive expertise in combining neuroimaging with brain stimulation to better understand the neural circuits underlying psychiatric disorders and improve treatment targeting. His research focuses on advancing precision medicine in neuromodulation by integrating brain stimulation with advanced neuroimaging techniques.
His research program includes two large clinical trials funded by the National Institute of Mental Health (NIMH) that use personalized functional MRI-defined targets for TMS treatment of major depressive disorder and posttraumatic stress disorder, respectively. These studies also employ concurrent TMS/fMRI to investigate how stimulation engages brain circuits in individual patients, providing mechanistic insights that may guide further optimization of treatment targeting. Additional exploratory projects use machine learning and fMRI-based brain-state decoding to further personalize TMS protocols, investigate novel TMS pulse parameters to enhance motor plasticity, and examine the timing of stimulation delivered through two TMS coils to optimize working memory enhancement. Dr. Oathes is building a larger research team at CU Anschutz, creating new opportunities for collaboration across psychiatry, neuroscience, neurosurgery, neuroimaging, and bioengineering. His recruitment strengthens the department's ability to translate advances in in brain imaging and circuit neuroscience into more precise, individualized psychiatric treatments.
Expanding the Frontiers of Deep Brain Stimulation In close collaboration with the Department of Neurosurgery, the Department of Psychiatry continues to advance DBS as a treatment and research platform for severe, treatment-refractory psychiatric disorders. In a significant recent milestone, the department obtained an FDA Investigational Device Exemption (IDE) for a clinical trial investigating DBS for treatment-refractory schizophrenia and schizoaffective disorder. Led by Rachel Davis, MD and Judith Gault, PhD, this investigatorsponsored study will evaluate DBS as a potential therapeutic approach for patients who have not responded adequately to existing treatments. The upcoming trial represents an important expansion of the department's psychiatric DBS research beyond established applications in OCD and provides another opportunity to translate advances in our understanding of brain circuitry into new therapeutic approaches. Through investments in clinical infrastructure, faculty recruitment, and innovative research, the Department of Psychiatry is building a comprehensive psychiatric neurotherapeutics program that expands access to advanced treatments while supporting the development of more precise, individualized interventions.
Pioneering New Possibilities in Deep Brain Stimulation A newly obtained FDA Investigational Device Exemption clears the way for a clinical trial exploring deep brain stimulation as a potential treatment for schizophrenia and schizoaffective disorder that have not responded to existing treatments.
RIPPLES OF IMPACT - 2026
REACH: NATIONAL
A NEW PATH TO HEALING: BRINGING SPECIALIZED PSYCHIATRIC CARE CLOSER TO HOME Written By Anastasia Klott and Thomas Zimmer
For children and adolescents living with severe mental health conditions, finding effective treatment can be a long and difficult journey. When medications, therapy, and other interventions have not been enough, families may find themselves searching far from home for specialized care. On July 6, 2026, the University of Colorado Department of Psychiatry launched a pediatric electroconvulsive therapy (ECT) service at Children’s Hospital Colorado, creating a new treatment option for young people with severe psychiatric illness. This is the fourth pediatric-focused ECT service to exist in the United States, and the only such program in the western two-thirds of the country. In its first few months, the program has already served patients and families across the state of Colorado and neighboring states. Some of these families had been trying to access ECT for chronic conditions for years. We have seen young people getting back to their lives, families and futures. A family heard their son talk for the first time in two years. A teen smiled for the first time in over a year. A child can read books again, something they had not been able to do in over three years. One of our first patients to complete their ECT course went from being hospitalized for six weeks at the beginning of the summer to starting their first year of college. They plan on becoming a pharmacist.
Their story reflects what the new service hopes to make possible—not simply providing a treatment, but helping young people move forward. The program also offers an opportunity to reduce the stigma and misconceptions surrounding ECT through shared decision-making with families, compassionate conversations, and education. By expanding access to specialized, evidence-based psychiatric care, the Department is helping ensure that young people and families have another option—and another reason for hope.
ONE IN ONLY FOUR NATIONWIDE We are home to one of only four pediatricfocused ECT services in the United States, and the only such program in the western twothirds of the country.
REACH: NATIONAL
MEETING YOUTH WHERE THEY ARE - AN INTEGRATED MODEL OF ADOLESCENT ADDICTION CARE Written By Sukhie Sandhu
PRISM expands access to evidencebased treatment for youth with substance use disorders, with particular attention to those with co-occurring mental health conditions
Substance use disorders are a leading cause of morbidity and mortality among adolescents and young adults, yet youth-specific addiction treatment remains scarce in Colorado. Because substance use often begins in adolescence, early access to evidencebased care is one of the most powerful ways to prevent long-term harm. In response to this gap and the youth opioid overdose crisis, Pediatric Mental Health Institute (PMHI) launched the Psychiatric Resource for Integrated Substance Use and Mental Health Care (PRISM) at Children’s Hospital Colorado (CHCO). .
At the heart of PRISM is the Addiction Consult Service, which launched hospital-wide at CHCO’s Anschutz Medical Campus in early 2026. The service provides specialized withdrawal management and treatment for youth in the emergency department and medical and psychiatric inpatient units.Since its launch, over 200 patients have seen an addiction medicine provider and the service has rapidly expanded to offer virtual consultation to emergency departments and inpatient units across the CHCO network, as well as PMHI partial hospitalization programs.
200+ PATIENTS Received specialized addiction care since PRISM's 2026 launch.
By embedding addiction expertise in settings where youth with complex, high acuity needs already receive care, PRISM turns these encounters into opportunities for treatment. This work lays the foundation for a comprehensive, integrated model of youth addiction care, one that improves access, supports recovery, and changes the trajectory of substance use for young people and their families.
RIPPLES OF IMPACT - 2026
REACH: NATIONAL
SHINING A SPOTLIGHT ON MENTAL HEALTH: A RECORD-BREAKING YEAR FOR THE JDC LUNCHEON Written By Matt Mishkind
On October 10, 2025, the Helen and Arthur E. Johnson Depression Center (JDC) held its 15th Annual Luncheon at the Seawell Ballroom with Gracie Gold, National figure skating Champion, Olympic Bronze Medalist, and award-winning author. The JDC's annual luncheon represents its largest fundraising event, with donations benefiting several initiatives including community-based education, clinical services, research, and workforce development. The 2025 luncheon was the most financially successful with about $725,000 raised and about $570,000 in net profit.
Aligned with the theme “Figuring it Out: Shining a Spotlight on Mental Health”, Graice and emcee, Reggie Rivers, had an enlightening fireside chat about her experiences being thrust into the world stage and learning to cope with the pressures and her own mental health journey that includes depression, anxiety, and an eating disorder. Close to 500 individuals attended the luncheon and the JDC’s first and longest-standing Board Chair, Heather Mulvihill, was awarded the inaugural George Wiegers Memorial Award honoring the JDC’s founder. Gracie also gave her time the evening before the luncheon and spoke to about 50 community members about mental health in sport.
RIPPLES OF IMPACT - 2026
REACH: NATIONAL
PARTNERING WITH PRIVATE INDUSTRY TO ADVANCE PUBLIC HEALTH: REAL WORLD DATA ON REGULATED PSILOCYBIN SERVICES IN COLORADO Written By Scott Thompson
A brief conversation led to a novel research collaboration— and the first look at how people experience regulated psilocybin services outside clinical trials. What happened? It was 2023. Colorado voters had just approved the Natural Medicines Initiative to create a regulated pathway for the provision of psilocybin, the psychedelic ingredient of magic mushrooms. The founder of a new start-up company, Niko Skievaski, who had previously worked in the electronic health records industry, came to meet with several Department of Psychiatry faculty members to discuss the current state of psychedelic drug development. Dr. Thompson pulled him aside at the end of the meeting with a request – could he help develop a way to capture the experiences of people who receive psilocybin in the regulated pathway? Dr. Thompson recognized that the Colorado experience would be ‘experimental’ because it was open to anyone, unlike all previous clinical traditional trials, in which subjects are rigorously screened for conditions that can cause them to be excluded. The Colorado experience would provide the first ‘real world’ data. Niko agreed to create a data collection process. Fast forward to 2026. Niko’s company, Althea PBC, is now providing services to a majority of regulated psilocybin providers in CO and OR, helping them with finances, record keeping, and other regulatory tasks required by the state. Niko shares with Dr. Thompson a massive spreadsheet containing data from 2363 individuals that used Colorado and Oregon regulated psilocybin services between December 2024 and March 2026. Analysis of the data offered a rare opportunity to examine psilocybin use outside the clinical trial setting. The findings shed light on why people seek psilocybin services, the doses of psilocybin they receive from their facilitators, and the relationship between dose and the intensity of their subjective experience (i.e. the “trip”). The analysis also examined selfreported depression, anxiety, emotional well-being two weeks after dosing using well established psychiatric instruments. We also gathered extensive data about adverse events during and after dosing.
Scott Thompson, PhD
What did we learn? Although there are very significant limitations of our dataset, we concluded that regulated psilocybin services, as provided in the Colorado model, are effective in reducing self-perceived mental health challenges in the real world outside of the clinical trial setting. The benefits were largely consistent with the results of clinical trials, which is reassuring. While there was largely no evidence of significant safety issues, we did see concerning evidence of potential changes in suicidal thinking, which requires much more detailed follow-up. A paper describing our results has been submitted for publication. Why does this matter? Given the rapid expansion of access to psilocybin services across the globe in non-clinical settings, this first-of-its-kind data is likely to have significant impact on policy makers, the public, and psychiatrists, who are facing increased questions about such services from their patients. By combining the Department’s scientific expertise with a commercial partner’s connection to the regulated service system, we created an opportunity to study an evolving practice at a scale and in a setting that would otherwise have been difficult to access. What began as a conversation after a meeting has developed into a novel research effort with the potential to inform clinical practice, public policy, and the responsible delivery of psychedelic services.
RIPPLES OF IMPACT - 2026
REACH: NATIONAL
CONNECTING SYSTEMS. IMPROVING CARE.
MY WORK IN CORRECTIONAL PSYCHIATRY Written By Morgan Deal
While working at the Colorado Department of Corrections (CDOC) as a forensic psychiatry fellow from 2021 to 2022, I saw many opportunities to improve mental health care in our prison system. I expected to return to CDOC after finishing my training because I enjoyed working within complex systems of care and found fulfillment in working with incarcerated patients. I also believed that anyone, including me, could improve an intimidating, inefficient system over time with persistence, especially if the goal was providing quality patient care. I returned to CDOC in January 2024, and in July 2026, I was honored to be selected as CDOC’s inaugural Lead Psychiatrist for Residential Treatment Programs. In my new role, I am responsible for overseeing the psychiatric care of more than 500 patients with serious mental illness (SMI) across Colorado. My life’s work is to provide exceptional care for people with SMI who interact with the legal system and to research more effective treatment interventions for this severely underserved population. In this role, I will develop more effective treatment programming within CDOC, strengthen the continuum of care for people with SMI by improving CDOC’s collaboration with other state mental health agencies, and conduct high-quality research to improve correctional psychiatric care nationwide. Last year I was incredibly fortunate to receive the prestigious Charles Dike Scholarship from the American Academy of Psychiatry and the Law (AAPL). My hope is to partner with AAPL to publish critical research on effective treatments for incarcerated people with SMI.
I believed that anyone, including me, could improve an intimidating, inefficient system over time with persistence, especially if the goal was providing quality patient care.
REACH: NATIONAL
TURNING KNOWLEDGE INTO ACTION: HOW VITALCOG IS CHANGING CONVERSATIONS ABOUT SUICIDE Written By Matt Mishkind
Since 2024, the monthly number of
1,400+ CERTIFIED TRAINERS VitalCog's expanding network of peer trainers brings accessible suicide prevention education into workplaces and communities across multiple industries. The Johnson Depression Center (JDC) has expanded its VitalCog: Mental Health and Suicide Education programs over the past few years with significant changes in 2026. VitalCog is a brief suicide prevention community-helper training program for workplaces that has been adapted for different industries and communities including construction (also available in Spanish), athletics, and the extraction industry. Designed to be delivered in less than two hours by peer trainers in both office and field settings, the JDC utilizes a network of over 1,400 certified trainers for broad dissemination.
individuals trained has increased by 108%, the number of monthly trainings has increased by 40%, the average number of participants per training has increased by 50%, and the number of external VitalCog trainers has increased by 86%. VitalCog now reaches over 15,000 individuals a year. VitalCog programming has demonstrated statistically significant increases in knowledge gained among program participants as well as increased comfort in talking to others about suicide, and intent for behavior change. A 3-month follow-up evaluation showed that training participant outcome improvements were maintained from baseline over time, and resulted in self-reported behavioral interventions by both peers within the construction industry and from program trainees to those outside of the industry. Part of this evaluation suggests that each trainee talked to about 5.5 other individuals about the training and 20% actively engaged with someone at risk of suicide or in a mental health crisis and used skills that were taught in VitalCog.
RIPPLES OF IMPACT - 2026
REACH: GLOBAL
THE IMPORTANCE OF INTERNATIONAL TRAINEES IN ADVANCING PRECLINICAL AND TRANSLATIONAL RESEARCH Written By Tracy Bale
The Bale laboratory’s international trainees are essential to our scientific productivity, innovation, and collaborative reach. We currently have four Brazilian researchers who bring complementary expertise and perspectives shaped by their training and research experiences in Brazil, Europe, and the United States. Rodrigo Orso and Kerstin Creutzberg joined our laboratory after conducting research in Brazil, Italy, and Denmark, bringing diverse preclinical research expertise and approaches. Arthur Feltrin, who had already spent several years conducting research in the United States, contributes specialized expertise in computational biology. We are also hosting Bruna, a PhD student from Brazil completing a visiting research period in our laboratory. Together, these researchers strengthen our multidisciplinary research environment and build meaningful scientific connections across countries and institutions.
International researchers bring more than expertise. They build lasting bridges between scientific communities, advancing discovery through connections that endure across borders.
International postdoctoral researchers bring more than technical expertise; they create lasting bridges between research communities. By maintaining relationships with institutions and colleagues in their home countries and previous training environments, they facilitate new collaborations, strengthen access to specialized expertise and research cohorts, and create opportunities for scientific exchange and training. These connections expand CU Anschutz’s collaborative reach and the Department’s visibility, helping establish partnerships that can extend well beyond any individual trainee’s appointment.
Our Brazilian researchers have made
The impact of international trainees
important contributions across the continuum of preclinical and translational research, from molecular and mechanistic studies to investigations and computational analyses involving large clinical cohorts and clinical trials that underlie the formation of NeuroVesica. They have helped establish and advance sophisticated molecular biology approaches, generate and interpret complex longitudinal datasets, and apply computational biology and machinelearning methods to identify meaningful patterns in multidimensional data. Integrating these capabilities enables our laboratory to connect biological mechanisms with clinically relevant questions in psychiatry and neuroscience. Their contributions have supported publications and grant applications, expanded our capacity for translational discovery, and helped advance innovative research with potential clinical applications, including the development of multiple provisional patents.
extends throughout the laboratory. They mentor students and staff, introduce new techniques and analytical approaches, and broaden the scientific perspectives of colleagues at every career stage. They also help trainees understand that scientific progress depends on the exchange of ideas, expertise, and resources across borders. Cultural diversity improves the lab’s depth and breadth, enabling everyone to look through a wider lens at their project and interpretation of their results.
The diversity of scientific training and cultural perspectives that international
These relationships often endure for decades. Some international postdoctoral researchers may remain at CU Anschutz and contribute as faculty or independent investigators; others establish careers and laboratories elsewhere while maintaining active collaborations. Each trainee therefore represents not only an individual scientific contribution but also an opportunity to build enduring partnerships among researchers, institutions, and countries. Supporting international trainees strengthens our research enterprise, advances preclinical
researchers bring is particularly valuable in interdisciplinary fields such as psychiatry. Our research integrates molecular biology, neuroscience,
discoveries toward clinical application, and reinforces the global collaborations essential to the future of biomedical science.
physiology, computational science, and clinical investigation approaches.
REACH: GLOBAL
GLP-1 WEIGHT-LOSS DRUGS TO TREAT SUBSTANCE USE DISORDERS Written By Angel Tran with support from Joseph Schacht
For more than 20 years, Joseph Schacht, PhD, has studied the neuroscience of addiction, seeking to understand why people develop alcohol use disorder and how to help them regain control. Throughout his career, one challenge has remained constant: the need for more effective treatment options. Now, an unexpected discovery is offering new hope. Medications originally developed to treat diabetes and obesity, known as GLP-1 receptor agonists, are showing promising potential to reduce alcohol consumption and cravings. At the University of Colorado Anschutz School of Medicine, Schacht and his research team are exploring whether these medications could change the future of addiction treatment. The results of their latest clinical trial are encouraging. Dr. Schacht and his team recruited 50 adults with moderate to severe alcohol use disorder who wanted to reduce their drinking.
Over eight weeks, participants received either oral semaglutide, the active ingredient in Ozempic and Wegovy, or a placebo. The findings were striking. Participants taking semaglutide consumed approximately half as many drinks on days when they drank. They also reported significantly reduced alcohol cravings, fewer alcohol-related problems and less marijuana use. For researchers who have spent decades studying addiction, these findings represent an exciting step forward. Alcohol use disorder affects millions of Americans, devastating individuals, families and communities. Yet no new medication has been approved by the FDA specifically to treat this condition since 2006. Existing medications help some patients, but they don't work for everyone. One particularly promising aspect of this research is that semaglutide may help people moderate their drinking without requiring complete abstinence. Many individuals struggling with alcohol use disorder aren't necessarily seeking to stop drinking altogether. They want to regain control over their choices, their health and their lives. The findings suggest that medication could help them do exactly that. Important questions remain. Larger, longer studies are needed to understand whether the benefits persist, how different populations respond and whether lower doses might be equally effective. Researchers also need to determine what happens when patients discontinue treatment. Beyond its clinical possibilities, this research could help change how society understands addiction. For too long, people with substance use disorders have faced judgment and stigma, with addiction often viewed as a failure of willpower or character. Neuroscience tells a different story. Addiction has a biological basis, involving brain systems that regulate motivation, reward and behavior. The possibility that medication can reduce the desire to drink reinforces an important message: Addiction is a medical condition, not a personal failing. That understanding can help replace stigma with compassion and open the door to more effective care. While research into GLP-1 medications and addiction treatment remains in its early stages, these findings offer genuine reasons for optimism. And for millions of people seeking a healthier relationship with alcohol, that hope could make all the difference.
BUILDING CONNECTIONS. CHANGING CONVERSATIONS. REACH: GLOBAL
FROM ONE PROGRAM TO GLOBAL IMPACT: A DECADE OF COMMUNITY CONNECTIONS Written By Matt Mishkind
The Johnson Depression Center’s (JDC) mission is to improve the lives of people in Colorado and beyond who suffer from mood and related disorders through clinical excellence, innovative care models, research, community engagement, and workforce development. While community engagement has been part of the mission since its founding, it was in 2016 when the JDC’s Advisory Board decided to focus on the need for training and education that is community-focused and accessible. Community Programs were then formalized through a local community grant focused
In the past 10 years, the JDC Community Programs has grown from one program serving hundreds to an international collective where a JDC program is delivered over 16 times each week.
specifically on delivering community-based suicide prevention training. From that modest beginning, JDC Community Programs is now comprised of over 20 programs and has directly touched over 80,000 lives in communities across Colorado, the nation, and internationally. Indirectly, the Community Programs team touches lives through its peer-reviewed publications, professional presentations, and engagements with media sources.
Community Programs are broadly defined as a training, program, or other educational activity in partnership with or facilitated by the JDC that does not include the direct delivery of clinical services. These diverse educational offerings are community-academic partnerships designed to increase understanding of mental illness and wellness, reduce stigma, prevent suicide, and increase access to quality mental health care. Community Programs are delivered in a range of communities and community settings, in schools, businesses and other organizations, and to specific professional groups. While the original goal of providing free and low-cost training remains a focus, the JDC has diversified its revenue sources to include grants, contracts, philanthropy, and fee-for-service payments. The JDC Community Programs saw significant growth in 2026 with over 17,500 lives directly touched through its programming. VitalCog: Mental Health and Suicide Education continues to expand into new industries including a partnership with the National Institute for Occupational Safety and Heath (NIOSH) to modify programming for Extraction related to oil and gas, and mining industries. JDC has a longstanding partnership with the Colorado School of Public Health and recently collaborated on a VitalCog module Supporting Employees Affected by Substance Use Disorders training to assist recovery-friendly workplaces. The second annual Coalition of Athletic Communities for Mental Health (COACmH), which is a JDC initiative, was held February 17-19 on the Anschutz Campus. COACmH brings together over 200 individuals across the country and internationally and representing a broad array of sport roles and disciplines to identify common solutions to issues facing athletes and coaches. The JDC celebrates its 16th annual luncheon in 2026, which continues to bring together over 500 individuals to raise awareness and change conversations around mental health. The luncheon regularly raises over $500,000 to support JDC’s efforts to provide and expand community programs. Launched in 2022 through the generosity of several donors, the Colorado Bipolar Education Program (CoBE) is dedicated to educating patients, families, and providers about bipolar disorder to improve the lives of those affected by the illness.
RIPPLES OF IMPACT - 2026
REACH: GLOBAL
2025 PUBLICATIONS Publications were pulled with the criteria of having a PMID in PubMed. Because this report is being released prior to the end of 2026, last year’s publications are being shared in their entirety for this edition. All articles shared have at least one Psychiatry-affiliated author. Listings are shared by first author last name, regardless of author’s departmental affiliation. We have included a selection of our most impactful articles first, followed by a full publication list for 2025. Guha, A., Fu, Z., Calhoun, V., & Hutchison, K. E. (2025). Lifetime Cannabis Use Is Associated with Brain Volume and Cognitive Function in Middle-Aged and Older Adults. Journal of Studies on Alcohol and Drugs, 10.15288/jsad.25-00346. https://doi.org/10.15288/jsad.2500346. PubMed PMID: 41379083 Lebin, L.G., Wu, K.C., Pointer, O. et al. Psychiatric Considerations in Breast Cancer: an Integrative Review. Curr Psychiatry Rep 27, 782–794 (2025). https://doi.org/10.1007/s11920-025-01644-2 Horowitz, L. M., Merai, R., Shi, T., Schoenbaum, M., Snyder, D. J., Brahmbhatt, K., Bridge, J. A., & Pao, M. (2025). Achieving integrated healthcare in suicide prevention: Universal suicide risk screening in clinical practice. Academic Pediatrics, 25(3), Article 102615. https://doi.org/10.1016/j.acap.2024.102615 PubMed Cosgrove, K. T., Cornier, M. A., McHugo, M., Melanson, E. L., Hild, A., Kronberg, E., Thomas, E. A., Dodd, K., Claus, E. D., Tregellas, J. R., & Legget, K. T. (2025). Exercise and diet effects on delay discounting and related neurobiology in adults with overweight or obesity: A randomized trial. Obesity, 33(7), 1263–1274. https://doi.org/10.1002/oby.24307. PubMed PMID: 40384491 Effinger, D.P., Schalk, S.S., King J.L., Strong, J.R., O’Connell, C.K., Calderon, J.R., Kopecky, B.J., McCorvy, J.D., Thompson, S.M. (2025) Assessing the potential cardiovascular risk of microdosing the psychedelic LSD in mice. ACS Pharmacology and Translational Science. doi: 10.1021/acsptsci.5c00202, 2025.
ALL PUBLICATIONS - 2025 2025 Annual Report: JAACAP's Work to Advance Science Regarding the Impacts of Structural and Social Determinants of Health on Children's Mental Health: JAACAP Journals. (2025). J Am Acad Child Adolesc Psychiatry, 64(12), 1354-1361. https://doi.org/10.1016/j.jaac.2025.09.004 Ali, D. A., Hale, E., Ascencio, A., & Berkowitz, S. J. (2025). Antidepressant pharmacotherapy in childhood PTSD with and without comorbid ADHD: a nationwide retrospective study. Journal of Psychiatric Research, 190, 199-204. https://doi.org/10.1016/j.jpsychires.2025.08.002 Ali, D. A., Olstein, B. C., Vargas, L., Hale, E. W., Adi, A., Savin, D., & Epperson, C. N. (2025). Refugee and asylum seeker child and adolescent mental health: A systematic review of racial, ethnic, and contextual disparities. American Journal of Orthopsychiatry. https://doi.org/10.1037/ort0000858 Alshabani, N., Haws, J. K., Zlotnick, C., & Johnson, D. M. (2025). PTSD symptom networks during treatment among residents in domestic violence shelters. Journal of Counseling Psychology, 72(1), 1-14. https://doi.org/10.1037/cou0000771 Alshabani, N., Price, K., Kennedy, H., Haws, J. K., & Kimball, S. L. (2025). A Qualitative Study to Understanding Barriers to PTSD Treatment for Immigrants and Refugees in Primary Care. J Immigr Minor Health, 27(5), 877-881. https://doi.org/10.1007/s10903-025-01746-2 Ariefdjohan, M., Reid, D., & Fritsch, S. (2025). Youth Digital Dilemmas: Exploring the Intersection Between Social Media and Anxiety. Pediatric Clinics of North America, 72(2), 317-331. https://doi.org/10.1016/j.pcl.2024.09.006 Bacon, E., Loh, R., DeNardo, J., Rinehart, D., Simpson, S. A., & Al-Tayyib, A. (2025). Evaluating markers for methamphetamine use in electronic health records. Drug Alcohol Depend, 276, 112876. https://doi.org/10.1016/j.drugalcdep.2025.112876 Bacon, E., Podewils, L. J., Bender, B., Blum, J., Thurstone, C., Al-Tayyib, A., Mills, J., Tillman, A. R., & Shlay, J. (2025). A learning health system model for addressing substance use: Denver Health Center for Addiction Medicine. Learn Health Syst, 9(3), e70003. https://doi.org/10.1002/lrh2.70003 Barnard, L. M., Rosenberg, S., Brooks-Russell, A., Betz, M. E., & Schacht, J. P. (2025). Alcohol use, risk of suicide, and access to firearms among youth in Colorado. Cogent Mental Health, 5(1), 2607769. https://doi.org/10.1080/28324765.2025.2607769. PubMed PMID: 41509663 Benjamin, K. S., Taylor-Cavelier, S., & Kennedy, S. M. (2025). Parenting Responses as Transdiagnostic Treatment Targets in a Youth Partial Hospitalization Program. Child Psychiatry Hum Dev. https://doi.org/10.1007/s10578-025-01915-2
Bergink, V., Akbarian, S., Byatt, N., Chandra, P. S., Cirino, N., Dazzan, P., De Witte, L., Di Florio, A., Dolman, C., Jones, I., Kamperman, A., Mahjani, B., Meltzer-Brody, S., Munk-Olsen, T., Nagle-Yang, S., Osborne, L. M., Rasgon, N., Robakis, T., Thippeswamy, H.,…Payne, J. L. (2025). Postpartum Psychosis and Bipolar Disorder: Review of Neurobiology and Expert Consensus Statement on Classification. Biol Psychiatry. https://doi.org/10.1016/j.biopsych.2025.10.016 Bhatia, D., Berg, O., Davies, R., Mikulich Gilbertson, S., & Sakai, J. (2025). The Association Between Sexual Identity, Depression, and Adolescent Substance Use. Child Psychiatry Hum Dev, 56(4), 11291136. https://doi.org/10.1007/s10578-023-01630-w Bindseil, I., Stutzman, D. L., Schiel, M. A., Sheffield, K., & Hagman, J. (2025). Utility of Aripiprazole in the Treatment of Anorexia Nervosa in Children and Adolescents: A Retrospective, Descriptive, Matched Cohort Study. Journal of Child and Adolescent Psychopharmacology, 35(8), 471-478. https://doi.org/10.1089/cap.2025.0013 Botchway-Commey, E., CB, D. P., Pace, C., Ehrenreich-May, J., Kennedy, S. M., Williams, J., ZP, D. P., AM, D. P., Anderson, V., & Crowe, L. (2025). A waitlist randomised control trial of the unified protocol for the treatment of emotional disorders in children and adolescents with chronic medical conditions (The UP-CAM Study): protocol paper. BMC Psychol, 13(1), 873. https://doi.org/10.1186/s40359-025-03052-w Branagan, W. T., Reynolds, N., Pshak, T., & Nydam, T. (2025). Psychosocial Trends in Autotransplant Patients with Nutcracker Syndrome: A Single Center's Experience. Annals of Vascular Surgery, 119, 11-13. https://doi.org/10.1016/j.avsg.2025.04.123 Brandes, C. M., Clark, H. M., Demers, C. H., Davis, E. P., & Hankin, B. L. (2025). Evaluating a hierarchical structural model of psychopathology symptoms across pregnancy and the postpartum period. J Psychopathol Clin Sci. https://doi.org/10.1037/abn0001056 Bryan, A. D., Skrzynski, C. J., Giordano, G., Yang, J., Stanger, M., Bidwell, L. C., Hutchison, K. E., & Perreault, L. (2025). Cannabis Use is Associated with Less Peripheral Inflammation but Similar Insulin Sensitivity as Nonuse in Healthy Adults. American Journal of Medicine, 138(9), 1285-1295. https://doi.org/10.1016/j.amjmed.2025.05.002 Bryan, C. J., Simon, P., Wilkinson, S. T., Allen, M. H., Perez, J., Adler, C., Moon, K., Astorino, L., Carpenter, K. M., Misquitta, L., Brownlowe, K., Khazem, L. R., Hay, J., Starkey, A. G., Tartaglia, J., Winston, H., Simpson, S., Dager, A. D., & Feuerstein, S. (2025). A Digital Therapeutic Intervention for Inpatients With Elevated Suicide Risk: A Randomized Clinical Trial. JAMA Netw Open, 8(8), e2525809. https://doi.org/10.1001/jamanetworkopen.2025.25809
Cafferty, R., Dillon, M., Ambroggio, L., Anthony, B. J., Haasz, M., & O'Leary, S. T. (2025). Associations Between the Child Opportunity Index and Suicide Risk Factors Among Pediatric Emergency Department Youth. Journal of Adolescent Health. https://doi.org/10.1016/j.jadohealth.2025.08.013 Cafferty, R., Klott, A., Dafoe, A., Glaros, C., Dorsey, B., Haasz, M., Anthony, B. J., & O'Leary, S. T. (2025a). A Qualitative Study Exploring Adolescent and Caregiver Perspectives of Electronic Suicide Screening in the Emergency Department. Annals of Emergency Medicine, 86(4), 405-414. https://doi.org/10.1016/j.annemergmed.2025.04.022 Chen, M. Y., Kramer, E. B., Gibson, L. P., Bidwell, L. C., Hutchison, K. E., & Bryan, A. D. (2025). Investigating the Relationship Between Cannabis Expectancies and Anxiety, Depression, and Pain Responses After Acute Flower and Edible Cannabis Use. Cannabis Cannabinoid Res, 10(1), 71-80. https://doi.org/10.1089/can.2023.0264 Cheng, Z., Moser, A. D., Jones, J., Schneck, C. D., Miklowitz, D. J., Dillon, D. G., & Kaiser, R. H. (2025). Reinforcement Learning and Decision Making in Depression in Adolescents and Young Adults: Insights from a New Model of the Probabilistic Reward Task. Comput Psychiatr, 9(1), 268-283. https://doi.org/10.5334/cpsy.147 Cherewick, M., Reaven, J., Giri, P., Rai, R. P., Cruz, C. M., Leiferman, J. A., & Matergia, M. (2025). Neurodiversity, Social Support, and Mental Wellbeing: Pathways to Resilience Among Early Adolescents. Advances in Neurodevelopmental Disorders. https://doi.org/10.1007/s41252-02500469-7 Christensen, M., Culp, S., Campo, J. V., Bridge, J. A., & Horowitz, L. (2025). Evaluation of the Ask Suicide-Screening Questions (ASQ) tool, Item 9 of the Patient Health Questionnaire (PHQ), pain, and opioid screening to detect suicide risk among rural adult primary care patients. Journal of Rural Health, 41(3), e70064. https://doi.org/10.1111/jrh.70064 Christine, P. J., Blum, J., Tillman, A. R., Braun, H. M., Hinrichs, M., Hurley, H., & Al-Tayyib, A. (2025). Evaluation of a Novel Patient-Centered Methadone Restart Protocol. JAMA Netw Open, 8(8), e2529393. https://doi.org/10.1001/jamanetworkopen.2025.29393 Christofferson, E. S., Plevinsky, J. M., Triplett, K. N., Amatya, K., Arcona, Z., Bedard-Thomas, K., Christon, L., Cousino, M. K., Dawson, A. E., El-Behaldi, A. F., Grande, L. A., Lefkowitz, D. S., Mayersohn, G., Rich, K., & Schneider, L. M. (2025). The Role of Pediatric Psychologists in the Pre-Transplant Evaluation: A Practice Survey. Pediatr Transplant, 29(7), e70209. https://doi.org/10.1111/petr.70209 Coburn, S., Trojanowski, P. J., Vagadori, J., Hinds, P., Germone, M., Liu, E., Streisand, R., & Bost, J. (2025). Development and Validation of a Pediatric Celiac Disease-Specific Quality of Life Measure. American Journal of Gastroenterology, 120(5), 1116-1126. https://doi.org/10.14309/ajg.0000000000003132
Cohen, C. C., Dabelea, D., Sinha, M., Delamater, A. M., Glueck, D. H., Hockett, C. W., Hoskin, M. A., Manson, S., Mayer-Davis, E., Phimphasone-Brady, P., Powell, J. C., Wasak, D., Stamatoiu, A. V., Steinberg, R. I., & Sauder, K. A. (2025). A Randomised Controlled Trial Testing a Behavioural Intervention Program for the Prevention of Type 2 Diabetes Among American Indian Youth: The Tribal Turning Point Study. Pediatric Obesity, 20(12), e70053. https://doi.org/10.1111/ijpo.70053 Conners Edge, N. A., Trigg, A. B., Heller, S. S., Steier, A., Reinsberg, K., Ash, J., Williams, M., Perry, D. F., Eckley, L., Biccio, E., & Johnston, K. (2025). Consultant perception of the feasibility and effectiveness of infant and early childhood mental health consultation services provided virtually to early care and education. Infant Ment Health J, 46(6), 765-777. https://doi.org/10.1002/imhj.70026 Conroy, K. E., Hankin, B. L., Griffith, J. M., Demers, C. H., Fraley, R. C., Curran, M., Grote, N., & Davis, E. P. (2025). Change in psychosocial target processes during prenatal depression intervention: A randomized clinical trial. J Mood Anxiety Disord, 12, 100159. https://doi.org/10.1016/j.xjmad.2025.100159 Cordova-Ramos, E. G., Miller, E., & Klawetter, S. (2025). Supplemental Security Income for Low-BirthWeight Infants-Addressing Gaps in Coverage. JAMA Pediatr, 179(6), 598-599. https://doi.org/10.1001/jamapediatrics.2024.6268 Cosgrove, K. T., Cornier, M. A., McHugo, M., Melanson, E. L., Hild, A., Kronberg, E., Thomas, E. A., Dodd, K., Claus, E. D., Tregellas, J. R., & Legget, K. T. (2025). Exercise and diet effects on delay discounting and related neurobiology in adults with overweight or obesity: A randomized trial. Obesity (Silver Spring), 33(7), 1263-1274. https://doi.org/10.1002/oby.24307 Cummings, C., Shircliff, K., Gatto, A. J., Rizzo, C. J., & Houck, C. D. (2025). Cluster analysis of caregiver and adolescent emotion regulation and its relation to sexual health and dating communication. J Pediatr Psychol, 50(4), 346-353. https://doi.org/10.1093/jpepsy/jsaf012 Delbasso, C. A., Mujica, C. A., Amaya, S., Mullican, K. N., Salamanca, N. K., Leone, R. M., Orchowski, L. M., Davis, K. C., Kaysen, D., Gilmore, A. K., & Lopez, C. (2025). Anxiety coping motives moderate links between discrimination and alcohol use in immigrant-origin and non-immigrant LGBQ+ college student. Alcohol Clin Exp Res (Hoboken), 49(11), 2592-2603. https://doi.org/10.1111/acer.70174 Denu, Y., Moore, K., Kenyon, D. B., Puumala, S. E., Wesner, C., & Danzi, B. A. (2025). From Vulnerability to Hope: Experiences with COVID-19 over Time in Rural America. Healthcare (Basel), 13(21). https://doi.org/10.3390/healthcare13212752 Dickson, K. S., Galligan, M., Holt, T., Kenworthy, L., Anthony, L., Roesch, S., & Brookman-Frazee, L. (2025). Randomized Feasibility Pilot of an Executive Functioning Intervention Adapted for Children's Mental Health Settings. Journal of Autism and Developmental Disorders, 55(7), 2407-2421. https://doi.org/10.1007/s10803-024-06365-8
Dickson, K. S., Kennedy, S. M., Safer, J., Brookman-Frazee, L., Roesch, S., & Anthony, L. G. (2025). Study protocol for a hybrid type 2 effectiveness-implementation trial of two interventions for autistic and non-autistic youth in children's mental health settings: one tailored for neurodivergence and one universal. Implement Sci Commun, 6(1), 131. https://doi.org/10.1186/s43058-025-00799-6 Dieujuste, N., Mann, A., Dunbar, K., Thibodeau, P. S., Fainstad, T., & Holliman, B. D. (2025). Understanding Challenges Faced by Female Graduate Medical Education Trainees: A Qualitative Content Analysis of Physician Coaching Requests. HCA Healthc J Med, 6(4), 319-329. https://doi.org/10.36518/2689-0216.1991 Dodd, K., McHugo, M., Sarabia, L., Wylie, K. P., Legget, K. T., Cornier, M. A., & Tregellas, J. R. (2025). CICADA: An automated and flexible tool for comprehensive fMRI noise reduction. Imaging Neurosci (Camb), 3. https://doi.org/10.1162/IMAG.a.114 Duffy, J. R., Sturm, E. T., Sares, A. G., Sarabia, L., Delao, E. M., K, M. B., Colmenares, A. M., Manavi, R. M., Rojas, D. C., Tregellas, J. R., Young, J. W., & Thomas, M. L. (2025). Psychometric Evaluation of Cognitive and Positive Valence Tasks Chosen for the NIMH Research Domain Criteria Project. Assessment, 32(6), 819-838. https://doi.org/10.1177/10731911241280770 Duffy, K. A., Sammel, M. D., Page, C. E., & Epperson, C. N. (2025). Invisible Scars: Residual Consequences of Childhood Maltreatment Even in Adults Classified as Resilient. Child Maltreat, 10775595251387057. https://doi.org/10.1177/10775595251387057 Dugré, J. R., Hopfer, C. J., & Winters, D. E. (2025). The dark sides of the brain: A systematic review and meta-analysis of functional neuroimaging studies on trait aggression. Aggression and Violent Behavior, 81, 102035. https://doi.org/https://doi.org/10.1016/j.avb.2025.102035 Duncan, C. L., Muther, E. F., Lindwall, J. J., Durkin, K., Ruvalcaba, E., Williamson, E., Ahrabi-Nejad, C., Bord, E., Green, A., Harrison, M. L., & Polineni, D. (2025). Using Community Engagement to Create a Telecoaching Intervention to Improve Self-Management in Adolescents and Young Adults With Cystic Fibrosis: Qualitative Study. Journal of Participatory Medicine, 17, e49941. https://doi.org/10.2196/49941 Effinger, D. P., Schalk, S. S., King, J. L., Wallingford, J. R., O’Connell, C. K., Calderon, J. R., Kopecky, B. J., McCorvy, J. D., & Thompson, S. M. (2025). Assessing the Potential Cardiovascular Risk of Microdosing the Psychedelic LSD in Mice. ACS Pharmacology & Translational Science, 8(11), 39233931. https://doi.org/10.1021/acsptsci.5c00202 Epperson, C. N., Davis, R., Dempsey, A., Haller, H. C., Kupfer, D. J., Love, T., Villarreal, P. M., Matthews, M., Moore, S. L., Muller, K., Schneck, C. D., Scott, J. L., Zane, R. D., & Frank, E. (2025). The Trifecta of Industry, Academic, and Health System Partnership to Improve Mental Health Care Through Smartphone-Based Remote Patient Monitoring: Development and Usability Study. JMIR Form Res, 9, e57624. https://doi.org/10.2196/57624
Erhart, A., Watamura, S., Olsavsky, A. K., Dufford, A., Tribble, R., Yeh, T., & Kim, P. (2025). Maternal cortisol concentration is associated with reduced brain activation to infant cry and more intrusive parenting behavior. Psychoneuroendocrinology, 171, 107207. https://doi.org/10.1016/j.psyneuen.2024.107207 Everhart, R. S., Saavedra, M. T., Ford, C. R., Gibson, S. L., Reid, F., Muther, E. F., Duncan, C. L., Cravens, R., Green, A., & Riekert, K. A. (2025). Mental health and adherence in CF: Self-efficacy and perceived barriers as mediators. J Cyst Fibros, 24(2), 334-340. https://doi.org/10.1016/j.jcf.2025.02.016 Fakhri, A., Ritvo, A., Casarella, J., & Tang, Y. L. (2025). Opioid use disorder and concurrent benzodiazepine use: clinical risks and management strategies. Journal of Addictive Diseases, 1-8. https://doi.org/10.1080/10550887.2025.2593244 Feldman, M.A., Agoston, A.M., Burnside, A.N., Emerson, N.D., Mudd, E., Koehn, K.Z., Gallanis, L.E. (2025) Management of High Acuity Patients in Pediatric Medical Settings: The Role of Consultation/Liaison Psychologists During the Growing Mental Health Crisis. J Clin Psychol Med Settings 32, 8–18. https://doi.org/10.1007/s10880-024-10010-y Fleegler, E. W., Vargas, L., Pulcini, C. D., & Hargarten, S. (2025). Bullets as Pathogen-The Need for Public Health and Policy Approaches. JAMA, 333(7), 565-566. https://doi.org/10.1001/jama.2024.25535 Garcia-Ramirez, G., Ellis, J. R., Salamanca, N. K., Mullican, K. N., Leone, R. M., Orchowski, L. M., Davis, K. C., Kaysen, D. L., & Gilmore, A. K. (2025). Alcohol Use, Sexual Assault Severity, and Bystander Opportunities and Behaviors Among College Students. J Interpers Violence, 8862605251368848. https://doi.org/10.1177/08862605251368848 Gardner, A., Bilyeu, C., Bazurto, L., Michalsen, K., & Carlson, C. (2025). Getting by with a little help from avatar friends: Use of AI-powered avatars to implement feedback training for faculty. Medical Teacher, 1-4. https://doi.org/10.1080/0142159X.2025.2534073 Gatto, A. J., McNamara, R. S., Ko, H., O'Brien, V. C., Jones, S. B., Cooper, L. D., & Kablinger, A. S. (2025). An EPIC transition: Rapid conversion of a measurement feedback system in behavioral health. Digit Health, 11, 20552076251359133. https://doi.org/10.1177/20552076251359133 Gault, J. M., Cascella, N., Moukaddam, N., Lehto, S., Hosokawa, P., Appelbaum, P. S., Sawa, A., Lippman-Bell, J., Anderson, W. S., Goodman, W., Sheth, S. A., Kramer, D., Thompson, J. A., Saks, E. R., & Davis, R. A. (2025). Ethical considerations of deep brain stimulation for treatment refractory schizophrenia: surveying stakeholders. BMC Psychiatry, 25(1), 796. https://doi.org/10.1186/s12888025-07128-0
Giljen, M., Healey, L. V., Bridgwater, M. A., Ceccolini, C. J., Friedman-Yakoobian, M., Horton, L. E., Lichvar, E., Mayanil, T., Mittal, V. A., Petti, E., West, M. L., & Schiffman, J. (2025). Clinical High Risk for Psychosis in Sexual and Gender Minority Populations: Considerations for Assessment and Treatment. J Am Acad Child Adolesc Psychiatry, 64(11), 1248-1254. https://doi.org/10.1016/j.jaac.2024.12.009 Gill, A. D., Spencer, K., Feldman, M. A., Giannini, C., Burnside, A. N., Mudd, E., Skedgell, K. K., Koehn, K. Z., Anderson, A., Emerson, N., Agoston, A. M., & Gallanis, L. (2025). The changing landscape of pediatric consultation-liaison psychology: Ethical considerations for the care of youth boarding in pediatric hospitals. Clinical Practice in Pediatric Psychology, 13(1), 99-110. https://doi.org/10.1177/21694826251319327 Gilmore, A. K., Leone, R. M., Reuben, K., Garner, J. B., Flowers, N., Chipman, T., Patton, E. E., Capobianco, J., Zong, Z. Y., Stappenbeck, C. A., Ellis, J. R., Fortson, K., Mullican, K. N., & Larimer, M. (2025). Pilot randomized controlled trial of a tailored personalized normative feedback intervention for college student alcohol use. Drug Alcohol Depend, 275, 112824. https://doi.org/10.1016/j.drugalcdep.2025.112824 Gilmore, A. K., Mullican, K. N., Moore, C. J., Mazzone, G. M., Ellis, J. R., Leone, R. M., Walter, K. H., Tomko, R. L., & Flanagan, J. C. (2025). Evaluating the feasibility of an experimental paradigm for alcohol-involved sexual violence perpetration among active duty and veteran men. Eur J Psychotraumatol, 16(1), 2538905. https://doi.org/10.1080/20008066.2025.2538905 Gilmore, A. K., Nielsen, K. E., Salamanca, N. K., Oesterle, D. W., Parekh, A., Leone, R. M., Orchowski, L. M., Ramakrishnan, V., Kaysen, D., & Davis, K. C. (2025). Preliminary Efficacy of Positive Change(+Change): A Pilot Randomized Controlled Trial of an Integrated Alcohol and Sexual Assault Prevention Program Tailored by Gender and Sexual Orientation. J Interpers Violence, 40(11-12), 2556-2581. https://doi.org/10.1177/08862605241275994 Glenn, E., Meyer, A., & Blakeley-Smith, A. (2025). Anxiety Self-Report in Autistic Adolescents With Intellectual Disability: Predictors of Parent-Youth Agreement. Am J Intellect Dev Disabil, 130(4), 323336. https://doi.org/10.1352/1944-7558-130.4.323 Glickman, A., Mikulich-Gilbertson, S., Abshire Saylor, M., DeGroot, L., & Bekelman, D. B. (2025). Relationship Status and Quality Are Associated With Perceived Benefits of Caregiving for People With Heart Failure. Journal of Cardiovascular Nursing, 40(4), E160-E166. https://doi.org/10.1097/JCN.0000000000001093 Gold, S. B., Costello, A., Gissen, M., Odman, S., Green, L. A., Stange, K. C., Swann, R., & Etz, R. S. (2025). How Are You Doing... Really? A Review of Whole Person Health Assessments. Milbank Quarterly, 103(1), 205-241. https://doi.org/10.1111/1468-0009.12727
Gonzalez, A., Haws, J. K., Alshabani, N., Zlotnick, C., & Johnson, D. M. (2025). Cyber abuse and posttraumatic stress disorder among racially diverse women who have resided in domestic violence shelters: A longitudinal approach. Psychological Trauma: Theory, Research, Practice and Policy, 17(Suppl 1), S105-S114. https://doi.org/10.1037/tra0001868 Gowin, J. L., Ellingson, J. M., Karoly, H. C., Manza, P., Ross, J. M., Sloan, M. E., Tanabe, J. L., & Volkow, N. D. (2025). Brain Function Outcomes of Recent and Lifetime Cannabis Use. JAMA Netw Open, 8(1), e2457069. https://doi.org/10.1001/jamanetworkopen.2024.57069 Gowin, J. L., Stallsmith, V., Weldon, K., Dooley, G., & Karoly, H. C. (2025). Effects of legal-market cannabis and alcohol on verbal learning and memory. Psychopharmacology. https://doi.org/10.1007/s00213-025-06882-z Grodin, E. N., Karoly, H., Browning, B. D., Coleman, L., Farokhnia, M., Kryszak, L. A., Meredith, L. R., & Squeglia, L. M. (2025). Utilizing blood inflammatory markers in alcohol studies: Considerations and recommendations for study design, sample collection, and data analysis. Neuroscience and Biobehavioral Reviews, 173, 106142. https://doi.org/10.1016/j.neubiorev.2025.106142 Guha, A., Fu, Z., Calhoun, V., & Hutchison, K. E. (2025). Lifetime Cannabis Use Is Associated with Brain Volume and Cognitive Function in Middle-Aged and Older Adults. J Stud Alcohol Drugs. https://doi.org/10.15288/jsad.25-00346 Gutierrez, A. L., & Limbers, C. A. (2025). Validation of the Sibling Perception Questionnaire in healthy siblings of children with chronic illnesses. Journal of Health Psychology, 30(2), 297–309. https://doi.org/10.1177/13591053241235095 Hale, A. E., Germone, M., Fahey, L., Stahl, M., Leonard, M. M., Singh, A., Hajjat, T., Mallon, D., Kerzner, B., Raber, C., Badalyan, V., Mehta, P., Liu, E., Shull, M., Absah, I., Lee, D., Ediger, T., Verma, R., Jericho, H.,…Raise, C. D. (2025). Measuring the Risk of Gluten Exposure: Development of the Gluten Exposure Risk Assessment in Pediatric Patients. American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000003675 Hale, E. W., Johnson, R. L., Cohan, T., Kelsay, K., & Stoddard, J. (2025). Study Preregistration: Typologies and Phenotypes of Youth Suicide Decedents. J Am Acad Child Adolesc Psychiatry, 64(12), 1446-1448. https://doi.org/10.1016/j.jaac.2025.03.020 Hale, E. W., Johnson, R. L., Cohan, T., Kelsay, K., & Stoddard, J. J. (2025). Typologies and Phenotypes of Youth Suicide Decedents. J Am Acad Child Adolesc Psychiatry. https://doi.org/10.1016/j.jaac.2025.12.009
Hammond, C. J., Fristad, M. A., Moon, Y. J., Batt, M. M., Dopp, R., Ghaziuddin, N., Hulvershorn, L., Leffler, J. M., Singh, M. K., Sullivan, A. E., Weinstein, S., & Miller, L. (2025). Differences in Cannabis and Cannabidiol Attitudes, Perceptions, and Behaviors Between US Adolescents Receiving Mood Disorder Treatment and Their Parents Across Legal Contexts. Int J Environ Res Public Health, 22(10). https://doi.org/10.3390/ijerph22101576 Hankin, B. L., Demers, C. H., Grote, N., Curran, M. C., Gallop, R. J., Camille Hoffman, M., & Davis, E. P. (2025). Enduring effects of brief interpersonal therapy on depression from pregnancy through 1-year postpartum: A randomized clinical trial. Journal of Mood and Anxiety Disorders, 13, 100165. https://doi.org/10.1016/j.xjmad.2025.100165 Harris, K. T., Beltran, G., Mosley, B., Sevick, C. J., Pyrzanowski, J., Wood, D., & Buchanan, C. (2025). Healthcare transition readiness in an adolescent and young adult urologic population: The ADHERENT study. J Pediatr Urol, 105699. https://doi.org/10.1016/j.jpurol.2025.105699 Haskins, C., Amspoker, A. B., Walder, A., Hogan, J., Ecker, A., Lindsay, J., & Shore, J. (2025). Telehealth Buprenorphine Initiation for Opioid Use Disorder Among American Indian and Alaska Native Veterans, April 2017-March 2023. Telemedicine Journal and e-Health, 31(11), 1333-1341. https://doi.org/10.1089/tmj.2025.0038 Hawks, J. L., Wojcieszak, Z. K., & Kennedy, S. M. (2025). Transdiagnostic, Stepped-Care Approach to Treating Youth Mental Health Concerns. Psychiatr Clin North Am, 48(4), 665-677. https://doi.org/10.1016/j.psc.2025.06.002 Haws, J., & Lack, C. (2025). Virtual Reality and Mental Health A Review of Current Findings and Needed Expansions. Psychiatric Clinics of North America. https://doi.org/10.1016/j.psc.2025.08.021 Hayutin, L., Middleton, C., Yankowitz, L., Boles, R., Blakeley-Smith, A., Meyer, A., Pickard, K., Reyes, N., Stahmer, A., & Reaven, J. (2025). All hands on deck: Training mental health and non-mental health school providers to deliver a CBT anxiety intervention for autistic students. School Mental Health 17, 289-300. https://doi.org/10.1007/s12310-024-09730-1 Hetelekides, E. M., McMichael, T., Tyskiewicz, A. J., Prince, M. A., Emery, N. N., Conner, B. T., & Karoly, H. C. (2025). Monthly simultaneous cannabis and alcohol use: effects on depression, anxiety, and stress in male and female college students. J Cannabis Res, 7(1), 87. https://doi.org/10.1186/s42238-025-00347-y Holmes, J., Dahlman, T., Bruns, E. J., Woody, M., Hendricks, M., Sweeney, M., & Anthony, B. J. (2025). Partnering with Family Organizations in Research: Experiences from the Field. Int J Environ Res Public Health, 22(6). https://doi.org/10.3390/ijerph22060894
Hooper, J., Stoliker, D., Wolfe, K., & Hutchison, K. (2025). Neuroaesthetics of the psychedelic state. Neuropsychologia, 217, 109238. https://doi.org/10.1016/j.neuropsychologia.2025.109238 Hooper, J. F., Ellingson, J. M., & Hutchison, K. E. (2025). Preliminary validation and refinement of the psychedelic aesthetic experience questionnaire. Frontiers in Psychology, 16, 1648968. https://doi.org/10.3389/fpsyg.2025.1648968 Horowitz, L. M., Lowry, N. J., Shi, T., Merai, R., Pao, M., & Bridge, J. A. (2025). Detecting Suicide Risk Among Pediatric Patients: Screening, Clinical Pathways, and Care. Annual Review of Clinical Psychology, 21(1), 305-325. https://doi.org/10.1146/annurev-clinpsy-081423-021101 Horowitz, L. M., Merai, R., Shi, T., Schoenbaum, M., Snyder, D. J., Brahmbhatt, K., Bridge, J. A., & Pao, M. (2025). Achieving Integrated Healthcare in Suicide Prevention: Universal Suicide Risk Screening in Clinical Practice. Acad Pediatr, 25(3), 102615. https://doi.org/10.1016/j.acap.2024.102615 Huber, R. S., Weinstein, S., Sullivan, A. E., Batt, M. M., Vande Voort, J., Westlund Schreiner, M., Are, F., Douka, I., DelBello, M., Singh, M. K., Hulvershorn, L., Boodoo, R., Hammond, C. J., Brasic, J. R., Ghaziuddin, N., Dopp, R., & Miller, L. (2025). Challenges and Opportunities in Using Cognitive Screeners for Adolescents and Young Adults With Bipolar Disorder. Focus (Am Psychiatr Publ), 23(2), 125-132. https://doi.org/10.1176/appi.focus.20240045 Hunte, R. S., Klawetter, S., Gill, M., Reed-Holden, D., & Cherry, K. (2025). Collaborative Anti-Racist Perinatal Care: A Case Study of the Healthy Birth Initiatives–Providence Health System Partnership. Genealogy, 9(3), 68. https://www.mdpi.com/2313-5778/9/3/68 Iwamoto, S. J., Halliday, T. M., Tregellas, J. R., Legget, K. T., Hild, A. K., & Cornier, M. A. (2025). Impact of Obesity on Appetite-Related Behaviors and Biomarkers in Older Adults: A Cross-Sectional Study. Obes Sci Pract, 11(3), e70076. https://doi.org/10.1002/osp4.70076 JAACAP Journals (2025). Children's Mental Health Research: Giving Our Nation's Children Our Very Best. Journal of the American Academy of Child and Adolescent Psychiatry, 64(10), 1112–1114. https://doi.org/10.1016/j.jaac.2025.05.008. PubMed PMID: 40409586 Joshi, S., Snyder, K. M., Thurstone, C., Rivera, B. D., Feldman, J., Cerda, M., & Krawczyk, N. (2025). Changes in psychosis-related emergency department and hospitalization rates among youth following cannabis legalization in Colorado. Drug Alcohol Depend, 273, 112719. https://doi.org/10.1016/j.drugalcdep.2025.112719 Kammeyer, R., Sillau, S., Chapman, K., Lindwall, J. J., Hutaff-Lee, C., & Schreiner, T. (2025). Selfreported quality of life related to cognitive function and fatigue in adults with multiple sclerosis. Mult Scler Relat Disord, 104, 106809. https://doi.org/10.1016/j.msard.2025.106809
Kenworthy, L., daVanport, S., Bascom, J., Ratto, A., Anthony, L. G., Khuu, A., Carel, E., Strang, J. F., Verbalis, A., Pugliese, C. E., Shen, J., Pelphrey, K. A., & Yang, J. S. (2025). Psychometric Investigation of Preliminary Item-Set for the Self-Assessment of Autistic Traits. Autism in Adulthood. https://doi.org/10.1177/25739581251366048 Kerns, C. M., Zaidman-Zait, A., Robins, D. L., Shattuck, P. T., Mazefsky, C. A., Newschaffer, C. J., & Berkowitz, S. J. (2025). Psychometric properties of the Childhood Adversity and Social Stress Questionnaire, Parent Report (CASSQ-PR), a measure tailored to assess stressful experiences and traumatic stress symptoms in autistic youth. Psychological Trauma: Theory, Research, Practice and Policy. https://doi.org/10.1037/tra0002007 Kirsch, D. E., Grodin, E. N., Leggio, L., McKee, S. A., Meredith, L. R., Mereish, E. H., Miranda, R., Jr., Nieto, S. J., O'Malley, S. S., Schacht, J. P., & Ray, L. A. (2025). The alcohol cue-exposure paradigm as a screening tool for alcohol use disorder medication development: A critical review. Alcohol Clin Exp Res (Hoboken), 49(11), 2412-2426. https://doi.org/10.1111/acer.70170 Kirsch, D. E., McManus, K. R., Grodin, E. N., Nieto, S. J., Miranda, R., Jr., O'Malley, S. S., Schacht, J. P., & Ray, L. A. (2025). Who is alcohol cue-reactive? A machine learning approach. Alcohol and Alcoholism, 60(5). https://doi.org/10.1093/alcalc/agaf052 Klawetter, S., Gievers, L., McEvoy, C. T., & Nicolaidis, C. (2025). NICU Parent and Staff Advocacy to Address Parental Mental Health. Clinical Pediatrics, 64(2), 247-256. https://doi.org/10.1177/00099228241260167 Lack, C., & Haws, J. (2025). Therapy Without a Therapist: Chatbots and Artificial Intelligence in Mental Health. Psychiatric Clinics of North America. https://doi.org/10.1016/j.psc.2025.08.018 Lebin, L. G., Blissett, G., Patel, K., & Metcalf, C. A. (2025). The Role of Menopause Hormone Therapy in Psychiatric Symptoms and Disorders: A Review of Evidence. Current Treatment Options in Psychiatry, 12(1), 19. https://doi.org/10.1007/s40501-025-00351-2 Lebin, L. G., Frew, J. R., Osborne, L. M., Standeven, L. R., & Nagle-Yang, S. (2025). Needs Assessment to Inform Future Development of the National Curriculum in Reproductive Psychiatry. Acad Psychiatry. https://doi.org/10.1007/s40596-025-02283-8 Lebin, L. G., Wu, K. C., Pointer, O., & Baurle, E. (2025). Psychiatric Considerations in Breast Cancer: an Integrative Review. Curr Psychiatry Rep, 27(12), 782-794. https://doi.org/10.1007/s11920-02501644-2 Lee, J.-Y., & Afzal, K. (2025). Clinical Considerations around the Development of Asian Boys and Mental Health Outcomes. Child and Adolescent Psychiatric Clinics, 34(4), 565-577. https://doi.org/10.1016/j.chc.2025.05.004
Lefkowitz, D. S., Triplett, K., Schneider, L., West, K., Anton, C., Rea, K. E., Brosbe, M., Christofferson, E. S., Christon, L., Kasparian, N., Lamari-Fisher, A., McIntyre, K., Plevinsky, J., Auerbach, S., Bansal, N., Benden, C., Dugan, M., Edelson, J., Gross-Toalson, J.,…Cousino, M. K. (2025). A consensus-based framework for the psychosocial evaluation of pediatric candidates for cardiothoracic transplant and ventricular assist devices. Journal of Heart and Lung Transplantation, 44(4), 487-502. https://doi.org/10.1016/j.healun.2024.11.028 LeMalefant, R., Myers, D., & Lebin, L. G. (2025). Dysphoric Milk Ejection Reflex: Recognition, Management, and Psychiatric Implications. Advances in Psychiatry and Behavioral Health, 5(1), 95102. https://doi.org/10.1016/j.ypsc.2025.02.005 Leone, R. M., Franklin-Kidd, M., Gayer, E., Brown, J., Patel, R., Thompson, C., Mullican, N. K., Salazar, L. F., Neighbors, C., Gilmore, A. K., Gray, K. M., & Senn, C. (2025). Integrating Alcohol and Cannabis Risk Reduction Into Sexual Assault Resistance Programming: Findings From a Pilot of EAAA. J Stud Alcohol Drugs, 86(5), 761-768. https://doi.org/10.15288/jsad.24-00183 Leone, R. M., Haikalis, M., Marcantonio, T. L., Gilmore, A. K., Stappenbeck, C., Barnett, N. P., & Gray, K. M. (2025). Event-level effects of alcohol, cannabis, and simultaneous alcohol and cannabis use on bystander intentions in response to hypothetical situations among college women. Addict Behav, 162, 108227. https://doi.org/10.1016/j.addbeh.2024.108227 Leone, R. M., Tomko, R. L., Hindocha, C., Hardeman, L., Tuttle, J., & Gray, K. M. (2025). Understanding US adolescents' and emerging adults' overestimation of their cannabis use quantity. Addict Behav, 161, 108206. https://doi.org/10.1016/j.addbeh.2024.108206 Marcantonio, T. L., Avery, G., Thrash, A., & Leone, R. M. (2025). Large Language Models in an App: Conducting a Qualitative Synthetic Data Analysis of How Snapchat's "My AI" Responds to Questions About Sexual Consent, Sexual Refusals, Sexual Assault, and Sexting. Journal of Sex Research, 62(9), 1905-1919. https://doi.org/10.1080/00224499.2024.2396457 Marcantonio, T. L., Leone, R. M., Mays, K., Thrash, A., Meadows, M., Manauis, C., Willis, M., LeRoux, S., & Jozkowski, K. N. (2025). How Does Alcohol Use Relate to Sexual Consent? A Scoping Review. Journal of Sex Research, 62(9), 1762-1780. https://doi.org/10.1080/00224499.2025.2555494 Marcantonio, T. L., Nielsen, K. E., Haikalis, M., Leone, R. M., Woerner, J., Neilson, E. C., & SchipaniMcLaughlin, A. M. (2025). Hey ChatGPT, Let's Talk About Sexual Consent. Journal of Sex Research, 62(4), 433-444. https://doi.org/10.1080/00224499.2023.2254772 McCabe, C. J., Ellingson, J. M., Hinckley, J. D., Stallings, M., Hopfer, C., Rhee, S. H., Corley, R. P., Gustavson, D. E., Ross, J. M., & Wall, T. L. (2025). Directional associations between antisocial behavior and alcohol use disorder symptoms from adolescence through adulthood: A sibling comparison cross-lagged approach. Alcohol Clin Exp Res (Hoboken), 49(9), 2092-2102. https://doi.org/10.1111/acer.70134
McClellan, B., Tamkin, V. L., Ehmer, A. C., & Frankel, K. (2025). The Diversity-Informed Tenets for Work with Infants, Children, and Families: Integrating Cultural Self-Awareness into Clinical Practice. Child Adolesc Psychiatr Clin N Am, 34(2), 157-167. https://doi.org/10.1016/j.chc.2024.07.015 McCool, M. W., Carpenter, R. W., & Ellingson, J. M. (2025). The role of distress tolerance in the momentary relationship between negative affect and drinking in daily life. Psychology of Addictive Behaviors. https://doi.org/10.1037/adb0001099 McNamara, I. A., Boissoneault, J., Ellingson, J. M., Sauer, J., & Carpenter, R. W. (2025). Associations of physical pain, alcohol use, and related factors in the daily lives of patients with chronic low back pain. Alcohol, 127, 73-83. https://doi.org/10.1016/j.alcohol.2025.06.002 McNitt, C., Asherin, R., Van Cleave, J., Young, S., Garvin, M., Whelan, K., Arp, N., Franklin, L., & Fritsch, S. (2025). Family Voices in Behavioral Health Extension for Community Health Care Outcomes for Primary Care Physicians. Pediatrics, 156(6). https://doi.org/10.1542/peds.2025-071148 Melkonian, V., Bischoff, A., Torre, L., Ketzer, J., Matkins, K., & Judd-Glossy, L. (2025). Congenital Colorectal Conditions: Caregiver Perspectives of Their Experience in the Neonatal Intensive Care Unit. American Journal of Perinatology, 42(8), 1083–1090. https://doi.org/10.1055/a-2463-4207 Merai, R., Shi, T., Wei, A. X., Ruch, D. A., Bridge, J. A., Pao, M., & Horowitz, L. M. (2025). The Moderating Role of Race/Ethnicity in Suicide Risk and Family Connectedness in Youth Presenting to the Emergency Department. JAACAP Open, 3(3), 448-454. https://doi.org/10.1016/j.jaacop.2024.10.009 Mescher, T., Hacker, R.L., Martinez, L.A.,Morris, C. D., Mishkind, M. C., & Garver-Apgar, C. E. (2025) Mobile Health Apps: Guidance for Evaluation and Implementation by Healthcare Workers. J. Technol. Behav. Sci. 10, 224–235. https://doi.org/10.1007/s41347-024-00441-7 Meyer, A. T., Pickard, K., Reyes, N., Boles, R., Hayutin, L., Middleton, C., Blakeley-Smith, A., & Reaven, J. (2025). Emotion regulation and behavior concerns: An examination of outcomes for a schoolbased CBT intervention for anxiety in students with autism or suspected autism. Research in Autism, 128, 202711. https://doi.org/https://doi.org/10.1016/j.reia.2025.202711 Moore, A., Lewis, B., Farrior, H., Hinckley, J., Nixon, S. J., & Bhatia, D. (2025). Impact of PreAdolescent Substance Familiarity on Subsequent Use: Longitudinal Analysis of Risk by Latent Classes in the Adolescent Brain Cognitive Development Sample. Substance Use & Misuse, 60(1), 1– 11. https://doi.org/10.1080/10826084.2024.2403109 Morford, A. E., Gonzalez, B., & Risser, H. J. (2025). Impact of online recruitment site and compensation amount on data integrity in an online survey study. Translational Issues in Psychological Science, No Pagination Specified-No Pagination Specified. https://doi.org/10.1037/tps0000453
Mueller, R. L., Hooper, J. F., Ellingson, J. M., Olsavsky, A. K., Rzasa-Lynn, R., Bryan, A. D., Bidwell, L. C., & Hutchison, K. E. (2025). A preliminary randomized trial of the safety, tolerability, and clinical effects of hemp-derived cannabidiol in alcohol use disorder. Front Psychiatry, 16, 1516351. https://doi.org/10.3389/fpsyt.2025.1516351 Mullin, B. C., Baumann, C., Meintzer, M. K., & Hawks, J. (2025). Training in Evidence-Based Assessment and Treatment of Pediatric Anxiety and OCD in a Large Hospital Outpatient Psychiatric Clinic. Evidence-Based Practice in Child and Adolescent Mental Health, 10(3), 569-578. https://doi.org/10.1080/23794925.2024.2358503 Nagle-Yang, S., Miles, A. G., Gores, A. M., & Moses-Kolko, E. (2025). Preventing Perinatal Suicide and Overdose: Innovative Care Models and Evidence-Based Strategies. Advances in Psychiatry and Behavioral Health, 5(1), 77-93. https://doi.org/10.1016/j.ypsc.2025.02.010 Naibauer, S., Branagan, W. T., Lehto, S., Reynolds, N., Mikulich-Gilbertson, S., Page, C. E., & Davis, R. A. (2025). Attitudes towards living organ donation: a cross-sectional survey study. Front Public Health, 13, 1552393. https://doi.org/10.3389/fpubh.2025.1552393 Nance, M., Miller, M. B., Ellingson, J. M., & Carpenter, R. W. (2025). Sleep quality and duration following the use and co-use of alcohol and cannabis in the daily life of community adults. Drug Alcohol Depend, 277, 112946. https://doi.org/10.1016/j.drugalcdep.2025.112946 Nokoff, N. J., Buchanan, C., & Barker, J. M. (2025). Clinical Manifestations and Treatment Challenges in Infants and Children With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. Journal of Clinical Endocrinology and Metabolism, 110(Supplement_1), S13-S24. https://doi.org/10.1210/clinem/dgae563 Nunes-Moreno, M., Furniss, A., Cortez, S., Davis, S. M., Dowshen, N., Kazak, A. E., Nahata, L., Pyle, L., Reirden, D. H., Schwartz, B., Sequeira, G. M., & Nokoff, N. J. (2025). Mental Health Diagnoses and Suicidality Among Transgender Youth in Hospital Settings. LGBT Health, 12(1), 20-28. https://doi.org/10.1089/lgbt.2023.0394 O'Malley, S. S., Miranda, R., Jr., Book, S. W., Chun, T. H., Liss, T., Malcolm, R. J., Muvvala, S. B., Padovano, H. T., Schacht, J. P., Blackburn, B., Diamond, I., Ransom, J., Ryan, M. L., Falk, D. E., & Litten, R. Z. (2025). Preliminary effects of oral ANS-6637, an ALDH2 inhibitor, on cue-induced craving, safety and alcohol consumption among adults with alcohol use disorder: a proof-of-concept, randomized, human laboratory trial. Alcohol and Alcoholism, 60(2). https://doi.org/10.1093/alcalc/agaf001
Olsavsky, A. K., Boggs, B., Dehinbo, O., Salem, T., Cason, A., Sierra, M., Lay, J., Sunday, D., Huber, K., Scott, S., Natvig, C., Mikulich-Gilbertson, S. K., Riley, V., & Sasson, C. (2025). Collaborating to Leverage American Heart Association's EmPOWERED to Serve Faith-Based Networks for Methamphetamine and Stimulant Misuse Educational Campaign in Black and Hispanic Churches. Psychiatr Res Clin Pract, 7(2), 100-108. https://doi.org/10.1176/appi.prcp.20240051 Ondusko, D. S., Klawetter, S., Hawkins Carter, E., Osborne, M., Peterson, J. W., Underwood Carrasco, V. I., Platteau, A., & Suzette Hunte, R. (2025). The Needs and Experiences of Black Families in the Neonatal Intensive Care Unit. Pediatrics, 155(1). https://doi.org/10.1542/peds.2024-067473 Opipari-Arrigan L, Kouril M, Connor J, Ford, C., McWilliams, E., Green, A., Siracusa, C., Milla, C., Muther, E., Nasr, S.Z., Sathe, M., Sawicki, G.S., Schechter, M.S., Snell, C., & Stark, L.J. (2025) Evaluating Feasibility, Acceptability, and Effectiveness of a Digital Behavioral Nutrition Intervention in Cystic Fibrosis Care. Clinical Practice in Pediatric Psychology, 13(3):269-279. doi:10.1037/cpp0000543 Parker, L., Donaldson, W., Morgan, E., Luxon, A. M., Russell, G. M., Terepka, A., Brightly-Brown, S., & New, C. (2025). Clinician’s digest: Clinically oriented article summaries for Volume 12, Issue 4. Psychology of Sexual Orientation and Gender Diversity, 12(4), 717-721. https://doi.org/10.1037/sgd0000893 Parrott, D., Leone, R. M., Hequembourg, A., Shorey, R. C., Eckhardt, C., & Stuart, G. L. (2025). An Integrative Model of Alcohol-Facilitated Intimate Partner Aggression Perpetration in Sexual and Gender Diverse Couples. J Stud Alcohol Drugs, 86(2), 218-228. https://doi.org/10.15288/jsad.2400008 Patel, L. R., O'Neill, M., Anzueto, G., Olsen, D., Pawlowski, K., Santoro, J. D., Sideridis, G., Spinazzi, N., & Baumer, N. T. (2025). Neurobehavioural Patterns in the Diagnosis of Autism Spectrum Disorder in Down Syndrome. J Intellect Disabil Res, 69(9), 809-821. https://doi.org/10.1111/jir.70015 Penwill, N. Y., Lalisan, A., Carubia, B., McNitt, C., Fritsch, S., Clark, B., Hyle, B., & Lockwood, J. M. (2025). Telepsychiatry Expansion of Inpatient Psychiatry Services During the COVID-19 Pandemic. Hosp Pediatr, 15(3), e126-e133. https://doi.org/10.1542/hpeds.2024-007942 Perzow, S. E. D., Hu, J., Bristol, M., Ruzicka, E. B., Clementi, M. A., Handing, E. P., Vargas, E., GutierrezColina, A. M., Gulley, L. D., & Shomaker, L. B. (2025). Systematic review and meta-analysis of psychological interventions for depression symptoms in young people with long-term physical health conditions. J Pediatr Psychol, 50(7), 699-714. https://doi.org/10.1093/jpepsy/jsaf049 Pinks, M. E., Van Deusen, K., Prince, M. A., Esbensen, A. J., Thurman, A. J., Patel, L. R., Abbeduto, L., Walsh, M. M., Daunhauer, L. A., & Fidler, D. J. (2025). Evaluation of a Modified Corsi Task to Assess Visuospatial Short-Term Memory in Young Children With Down Syndrome. Am J Intellect Dev Disabil, 130(3), 178-194. https://doi.org/10.1352/1944-7558-130.3.178
Podewils, L. J., Farrell, E., Loh, R., Gray, T. W., Witzke, D., & Stella, S. A. (2025). Exploring a shared vision for success in permanent supportive housing: a community-partnered study in Colorado, USA. Journal of Public Health Policy, 46(1), 110-126. https://doi.org/10.1057/s41271-024-00533-x Poudel, D. R., Sharma, A. K., Chapagain, R. H., Chapagai, M., Lowry, N. J., Sigdel, M. R., Bista, K. P., Pathak, R., Kunwar, A., Patterson, J., Carter, T., & Horowitz, L. M. (2025). Validity of the Nepali Ask Suicide Screening Questions tool for medical inpatients. BMC Psychiatry, 25(1), 719. https://doi.org/10.1186/s12888-025-07148-w Prisciandaro, J. J., Schacht, J. P., Prescot, A. P., & Anton, R. F. (2025). Brain glutathione levels and associations with recent drinking in treatment-naive individuals with alcohol use disorder versus light drinkers. Drug Alcohol Depend, 272, 112705. https://doi.org/10.1016/j.drugalcdep.2025.112705 Quintana, S., Aarons, G., Coser, A., Kominsky, T., Martin, L., Tsurnos, S., & Novins, D. (2025). Enhancing access to medication-assisted treatment in tribally-operated health and behavioral health systems: A qualitative study. J Subst Use Addict Treat, 171, 209635. https://doi.org/10.1016/j.josat.2025.209635 Ratto, A. B., Brandt, A., Cannon, L., Adler Werner, M., Alexander, K. C., Handsman, R., Campos, L., McKenna, J., Verbalis, A., Mikulich Gilbertson, S., Anthony, L. G., & Kenworthy, L. (2025). Development of unstuck and on target for early childhood: an executive function intervention targeting flexibility and self-regulation skills. Advances in Mental Health, 1-21. https://doi.org/10.1080/18387357.2025.2500374 Reaven, J., Cosgrove, K. T., Losh, A., Nickles, S., Kerns, C. M., Pickard, K., Blakeley-Smith, A., Hayutin, L., Meyer, A. T., Middleton, C., Reyes, N. M., & Boles, R. E. (2025). Facing your fears in schools: using the ADIS/ASA to characterize anxiety and intervention outcomes in students with autism or suspected autism. Front Psychiatry, 16, 1569435. https://doi.org/10.3389/fpsyt.2025.1569435 Ren, Z., Ellingson, J. M., Hopfer, C., Krueger, R. F., Krizan, Z., Markon, K. E., Ones, D. S., Panchal, Z., Ross, J. M., Vrieze, S., Zellers, S. M., & McGue, M. (2025). Sleep and Maladaptive Personality Traits: A Twin Study. Journal of Sleep Research, e70242. https://doi.org/10.1111/jsr.70242 Rittiphairoj, T., Leslie, L., Oberste, J. P., Yim, T. W., Tung, G., Bero, L., Riggs, P., Hutchison, K., Samet, J., & Li, T. (2025). High-Concentration Delta-9-Tetrahydrocannabinol Cannabis Products and Mental Health Outcomes : A Systematic Review. Annals of Internal Medicine, 178(10), 1429-1440. https://doi.org/10.7326/ANNALS-24-03819
Rivara, F. P., Richmond, T. S., Hargarten, S., Branas, C. C., Rowhani-Rahbar, A., Webster, D., Richardson, J., Jr., Ayanian, J. Z., Boggan, D., Braga, A. A., Buggs, S. A. L., Cerda, M., Chen, F., Chitkara, A., Christakis, D. A., Crifasi, C., Dawson, L., deRoon-Cassini, T. A., Dicker, R.,…Harms. (2025). Toward a Safer World by 2040: The JAMA Summit Report on Reducing Firearm Violence and Harms. JAMA, 334(24), 2208-2219. https://doi.org/10.1001/jama.2025.18076 Safer-Lichtenstein, J., Galicia, M., Umaña, I., & Galan-Torres, M. (2025). Pilot of an Online SpanishLanguage Support Group for Caregivers of Neurodivergent Children. Hispanic Journal of Behavioral Sciences, 47(4), 367-383. https://doi.org/10.1177/07399863251345949 Sakai, J. T., Epperson, C. N., Panchal, Z., Ali, D., Singhal, S., & Mikulich-Gilbertson, S. K. (2025). Trends in Individual Career Development Awards from National Institutes of Health to Physicians in Departments of Psychiatry (2013-2022). Acad Psychiatry, 49(1), 75-79. https://doi.org/10.1007/s40596-024-02027-0 Samet, J. M., Barrington-Trimis, J., Bero, L., Brooks-Russell, A., Buran, M., Dilley, J., Erickson, D., Huestis, M., Hutchison, K., Jeanne, T. L., Kosnett, M., Kroll, D. J., Lankenau, S., Miech, R., Pacula, R. L., Riggs, P., Soleimanpour, N., Teutsch, S., Tung, G., & Wang, G. S. (2025). Enhancing Methods for Research on Cannabis: A Workshop Report. J Cannabis Res, 7(1), 69. https://doi.org/10.1186/s42238-025-00314-7 Sanchez, C. R., Cooley, J. L., Winters, D. E., Ricker, B. T., & Fite, P. J. (2025). Associations between forms of aggression and peer victimization: Does prosocial behavior matter? Dev Psychopathol, 37(1), 415-428. https://doi.org/10.1017/S0954579423001694 Sannar, E. M., Winter, J., Franke, R. K., Werner, E., Rochowiak, R., Romani, P. W., Miller, O. S., Semmler, N., Bainbridge, J. L., Natvig, C., Mikulich-Gilbertson, S. K., & Tartaglia, N. R. (2025). Cannabidiol for treatment of irritability and aggressive behavior in children and adolescents with autism spectrum disorder: background and methods of the cannabidiol study in children with autism spectrum disorder study. Int J Clin Trials, 12(1), 29-37. https://doi.org/10.18203/2349-3259.ijct20250131 Savell, S. M., Page, E., Pan, J., Lillard, T. S., Emery, R. E., & Connelly, J. J. (2025). Epigenetic Modification of the Oxytocin Receptor in Pregnancy Predicts Parent-infant Bonding and Postpartum Depressive Symptoms. Journal of Child and Family Studies, 34(12), 3138-3148. https://doi.org/10.1007/s10826-025-03211-y Schmidt, J. C., Davis, R., Rapp, E., Rothman, M., & Fenstermacher, E. (2025). Case Report: Personalizing Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression for a Patient with Complex Medical History. Harvard Review of Psychiatry, 33(6), 319-327. https://doi.org/10.1097/hrp.0000000000000443
Seely, H. D., Still, L., Weinberger, E., Chen, E., Holmes, K., Loh, R., & Thurstone, C. (2025). Sociocultural Factors Impacting Substance Misuse and Treatment: A Latent Class Analysis of Youths Undergoing Combined Treatment. Future, 3(4), 25. https://www.mdpi.com/2813-2882/3/4/25 Shade, K. N., Ritvo, A. D., Silvernail, B., Finlayson, A. J. R., Bressi, J. E., Foster, D. E., Martin, I. J., Piper, C., & Martin, P. R. (2025). Long-term neurological consequences following benzodiazepine exposure: A scoping review. PloS One, 20(8), e0330277. https://doi.org/10.1371/journal.pone.0330277 Shah, K., Srinivas, S., Ashraf, S., Kagadkar, F., Kamrai, D., & Jain, S. (2025). Amnesia Associated With Recreational Cannabis Use in an Adolescent. Primary Care Companion to CNS Disorders, 27(5). https://doi.org/10.4088/PCC.23cr03562 Shi, T., Merai, R., Lowry, N. J., Ruch, D. A., Bridge, J. A., Pao, M., & Horowitz, L. M. (2025). The Relationships Between Nonsuicidal Self-Injury, Connectedness, and Suicide Risk in Youth Presenting to the Emergency Department. JAACAP Open, 3(3), 439-447. https://doi.org/10.1016/j.jaacop.2025.01.001 Shore, J. H., Synyahovskyy, V., Hukovskyy, O., Korostiy, V., McVeigh, F., & Poropatich, R. (2025). Technology in the Trenches: The Impact of evolving technologies on Combat Mental Health. Curr Psychiatry Rep, 27(2), 127-133. https://doi.org/10.1007/s11920-024-01581-6 Shore, J. H., Waugh, M., Levey, S. B., Calderone, J., Lyon, C., Holtrop, J. S., Gritz, R. M., Owen, V., McWilliams, S. K., & deGruy, F. (2025). Colorado integrated behavioral health plus (CIBH+): aligning behavioral health within a generalist approach to primary care. Frontiers in Psychology, 16, 1523369. https://doi.org/10.3389/fpsyg.2025.1523369 Simpson, S. A., Newton, C., Al-Tayyib, A., Duarte, K. G., Gilbert, A., Loh, R. M., & Rinehart, D. J. (2025). A Novel Care Navigation Intervention for Patients with Methamphetamine Use Disorder. Community Ment Health J. https://doi.org/10.1007/s10597-025-01570-w Singhal, S., Mause, E., Garcia, M. E., St Pierre, M., Ochoa-Frongia, L., & Dempsey, A. G. (2025). Quality of Psychiatric Care for Immigrants and People With a Non-English Language Preference: A Systematic Scoping Review. Psychiatr Serv, 76(4), 381-392. https://doi.org/10.1176/appi.ps.20240227 Smith, C. M., Weimann, K., Widick, M., Merritt, T., Christensen, H., Siegel, M., Pan, Z., & Gabriels, R. L. (2025). Best practices for physiological data collection in youth with autism and co-occurring mental health diagnoses: Implications for human-animal intervention research. MethodsX, 14, 103284. https://doi.org/10.1016/j.mex.2025.103284
Smith, M., Roberts, A., Elahi, S., Eihentale, L., O’Rourke, M., Meldrum, M., Ramos, B., Holley, C., Baker, S., Bustos, Y., Snider, M., Cicchetti, C., & Raviv, T. (2025). Efforts to Improve and Expand Implementation of Trauma-Responsive Schools: Findings from a Randomized Pilot of the Trauma Education to Advance Community Healing (TEACH) Program. School Mental Health, 17(2), 467-485. https://doi.org/10.1007/s12310-024-09739-6 Snodgrass, N. A., Fidler, D. J., Patel, L., Denne, E., Smith, J., Weber, S., & Esbensen, A. J. (2025). Relationship between anxiety and executive functioning among youth with Down syndrome. Research in Developmental Disabilities, 164, 105056. https://doi.org/10.1016/j.ridd.2025.105056 Soltani, A., Fidler, D. J., Patel, L., Voth, K., & Esbensen, A. J. (2025). Longitudinally Predicting Behavioral Challenges From Executive Functioning in Youth With Down Syndrome. Am J Intellect Dev Disabil, 130(2), 146-162. https://doi.org/10.1352/1944-7558-130.2.146 Spaderna, M., Rosenthal, E., Kang, S. J., Eyasu, R., Ebah, E., Ogbumbadiugha, O., Bijole, P., Cover, A., Davis, A., Zoltick, M., Kottilil, S., Mount, J., Gannon, C., Stevens, J., Garrett, G., Derenoncourt, M., Liu, T., Horowitz, L., Pao, M., & Kattakuzhy, S. (2025). Elevated rate of suicide risk in individuals with opioid use disorder. Am J Addict, 34(4), 440-449. https://doi.org/10.1111/ajad.70027 Stahl, M. G., Liu, E., & Catassi, C. (2025). Screening the general population for celiac disease: Lessons from the first international symposium held in Denver 2024. J Pediatr Gastroenterol Nutr, 81(2), 153-157. https://doi.org/10.1002/jpn3.70108 Stahl, M. G., Pan, Z., Germone, M., Nagle, S., Mehta, P., Shull, M., Griffith, I., Shuler, B., Hoffenberg, E., Taki, I., Geno-Rasmussen, C., Rewers, M. J., Norris, J. M., Liu, E., & Group, A. S. K. S. (2025). One-Year Outcomes Among Children Identified With Celiac Disease Through a Mass Screening Program. Clinical Gastroenterology and Hepatology, 23(7), 1135-1142. https://doi.org/10.1016/j.cgh.2024.03.030 Steidtmann, D., McBride, S., Mishkind, M., & Shore, J. (2025). From Couch to Click: Opportunities and Challenges of Hybrid Work Models in Mental Health Care. Curr Psychiatry Rep, 27(6), 385-392. https://doi.org/10.1007/s11920-025-01607-7 Steidtmann, D., Raffel, K. E., Green, J., MacPhee, E., Nagle-Yang, S., Schwenk, S., Cooke, D., Santisteban, A. C., & Dempsey, A. G. (2025). Using Technology to Support Measurement-Based Care: Design and Implementation of the Measurement-Assisted Care Program. Psychiatr Serv, 76(2), 126132. https://doi.org/10.1176/appi.ps.20240135 Stern, E. F., Ellingson, J. M., Schaefer, J. D., Hinckley, J. D., Stallings, M. C., Corley, R. P., Hopfer, C., Wall, T. L., & Rhee, S. H. (2025). Associations between cannabis use frequency and suicidal thoughts and behaviors: A clinical longitudinal sibling study. Addict Behav Rep, 22, 100620. https://doi.org/10.1016/j.abrep.2025.100620
Sugar, S., Lee, G., Kim, H., Hinckley, J., Vipler, E., & Coyle, T. (2025). Prevalence of screening positive for attention-deficit/hyperactivity disorder in adults seeking methadone for opioid use disorder. Addiction and Substance Abuse, 3, 8-11. https://doi.org/10.46439/addiction.3.009 Tanabe, J., Hickman, J., Tekriwal, A., Sakai, J., Abosch, A., Ojemann, S., Schacht, J. P., & Thompson, J. A. (2025). Electrophysiology and Functional Magnetic Resonance Imaging of Cue Craving: Potential Biomarkers for Therapeutic Neuromodulation in Addiction. Biological psychiatry global open science, 6(1), 100622. https://doi.org/10.1016/j.bpsgos.2025.100622. PubMed PMID: 41321424 Terasaki, D., Frank, J. W., & Schacht, J. (2025). Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial. J Addict Med, 19(2), 236-237. https://doi.org/10.1097/ADM.0000000000001393 Terasaki, D., Loh, R., & Simpson, S. (2025). Two Clinical Insights on Methamphetamine Withdrawal at a Safety-net Hospital. J Addict Med, 19(1), 118. https://doi.org/10.1097/ADM.0000000000001365 Thant, T. M., Khandai, A. C., Gillan, A., Peace, M., Quinn, D., & Levenson, J. (2025). Neuropsychiatric Symptoms of Subacute and Chronic Long COVID. American Journal of Psychiatry, 182(5), 498-499. https://doi.org/10.1176/appi.ajp.25182003 Thibodeau, P., Bosma, G. N., Hochheimer, C. J., Syed, A., Dieujuste, N., Mann, A., & Fainstad, T. (2025). The Moderating Effects of Moral Injury and Discrimination Trauma on Women Physician Trainees' Well-Being. Journal of General Internal Medicine, 40(11), 2679-2686. https://doi.org/10.1007/s11606-025-09434-5 Thibodeau, P., & Cutforth, A. (2025). Examining workplace trauma and moral injury among health care social workers: A secondary analysis [doi:10.1037/trm0000574]. Educational Publishing Foundation. Thurston, M. D., Ericksen, L. C., Jacobson, M. M., Bustamante, A., Koppelmans, V., Mickey, B. J., & Love, T. M. (2025). Oxytocin differentially modulates reward system responses to social and nonsocial incentives. Psychopharmacology, 242(3), 449-460. https://doi.org/10.1007/s00213-02406695-6 Thurstone, C., Etzig, C., Chen, E., Seely, H. D., & Loh, R. (2025). Mortality following adolescent substance treatment: 21-year follow-up from a single clinical site. Front Child Adolesc Psychiatry, 4, 1600101. https://doi.org/10.3389/frcha.2025.1600101
Torous, J., Ledley, K. T., Gorban, C., Strudwick, G., Schwarz, J., Choudhary, S., Emerson, M., Patriquin, M., Dempsey, A., Bantjes, J., Ospina-Pinillos, L., Hornick, J., & Kochhar, S. (2025). Accelerating Digital Mental Health: The Society of Digital Psychiatry's Three-Pronged Road Map for Education, Digital Navigators, and AI. JMIR Ment Health, 12, e84501. https://doi.org/10.2196/84501 Tran, K. T., Leone, R. M., Swartout, K. M., Tran, M. H., Trinh, O., & Yount, K. M. (2025). Sexual misconduct among high school students in Vietnam. Child Prot Pract, 5. https://doi.org/10.1016/j.chipro.2025.100150 Troppoli, T. A., & Thompson, S. M. (2025). A Comparison of Positive and Negative Allosteric Modulators of α5-Containing GABA(A) Receptors in the Treatment of Affective Disease. Biol Psychiatry. https://doi.org/10.1016/j.biopsych.2025.10.036 Troxel, M., Kraper, C., Verbalis, A., Safer-Lichtenstein, J., Seese, S., Ratto, A., Myrick, Y., Armour, A. C., Pugliese, C. E., Strang, J. F., Ba, C., Martucci, J., Biel, M. G., Jackson, V., Hardy, K. K., Mandell, D., Goode, T. D., Anthony, B. J., Kenworthy, L., & Anthony, L. G. (2025). Reaching "The Other Half": Teacher Referral Increases Inclusivity in Intervention Research for Neurodivergent School-Age Children. Journal of Clinical Child and Adolescent Psychology, 54(5), 578-591. https://doi.org/10.1080/15374416.2024.2303723 Vail, M., Newgren, J., Bindseil, I., Stutzman, D., & Margolis, E. (2025). Recognizing and Treating Catatonia in Kleefstra Syndrome. J Vis Exp(223). https://doi.org/10.3791/68333 van der Laan, C. M., Ip, H. F., Schipper, M., Hottenga, J. J., St Pourcain, B., Zayats, T., Pool, R., Krapohl, E. M. L., Brikell, I., Soler Artigas, M., Cabana-Dominguez, J., Llonga, N., Nolte, I. M., Bolhuis, K., Palviainen, T., Zafarmand, H., Gordon, S., Aliev, F., Burt, S. A.,…Boomsma, D. I. (2025). Genome-wide association meta-analysis of childhood ADHD symptoms and diagnosis identifies new loci and potential effector genes. Nature Genetics, 57(10), 2427-2435. https://doi.org/10.1038/s41588-02502295-y Van Deusen, K., Prince, M. A., Walsh, M. M., Patel, L. R., Pinks, M. E., Esbensen, A. J., Thurman, A. J., Abbeduto, L., Oser, C., Daunhauer, L. A., & Fidler, D. J. (2025). Modeling the Latent Factor Structure of the "EXcEEDS" (EXecutive function Early Evaluation in Down Syndrome) Battery. Am J Intellect Dev Disabil, 130(3), 195-208. https://doi.org/10.1352/1944-7558-130.3.195 Vargas, L. X., Ariefdjohan, M., Page, C. E., Meisel, Z. F., Ulrich, C. M., Alegria, M., Pimentel, N., Epperson, C. N., & Richmond, T. S. (2025). Field Notes from the Border: Lessons Learned in Conducting Mental Health Research Involving Newly Arrived Latinx Immigrants as Study Participants. J Immigr Minor Health, 27(1), 181-189. https://doi.org/10.1007/s10903-024-01643-0
Villarreal, R. I., Singhal, S., Dempsey, A. G., & Shore, J. (2025). The Future of Digital Mental Health: A Literature Review. Psychiatric Clinics. https://doi.org/10.1016/j.psc.2025.08.026 Walsh, M. M., Van Deusen, K., Prince, M. A., Esbensen, A. J., Thurman, A. J., Pinks, M. E., Patel, L. R., Feigles, R. T., Abbeduto, L., Daunhauer, L. A., & Fidler, D. J. (2025). Preliminary psychometric properties of an inhibition task in young children with Down syndrome. J Intellect Disabil, 29(1), 5-23. https://doi.org/10.1177/17446295231218776 Wei, A. X., Mournet, A. M., Ryan, P. C., Ruch, D. A., Pao, M., Horowitz, L. M., & Bridge, J. A. (2025). Suicide Risk and Social Connectedness in Cisgender and Transgender Lesbian, Gay, Bisexual, and Queer/Questioning Youth in the Emergency Department. Journal of Adolescent Health, 76(4), 599605. https://doi.org/10.1016/j.jadohealth.2024.11.241 Weisbrod, L. J., Schmidt, A. J., Tanabe, J., Sakai, J., Ojemann, S., Pawlowski, J. R., Shiffermiller, J. F., & Abosch, A. (2025). Deep Brain Stimulation for Methamphetamine Use Disorder: Perioperative Neuropsychiatric and Other Medical Considerations. Journal of Neuropsychiatry and Clinical Neurosciences, 37(3), 209-221. https://doi.org/10.1176/appi.neuropsych.20240142 Weishaar, M. G., Stephens, J. A., Prince, M. A., Wicklund, A., & Conner, B. T. (2025). Personality and social determinants of health predict adolescent comfort and honesty reporting sports-related concussion symptoms. Journal of Health Psychology, 30(9), 2144-2157. https://doi.org/10.1177/13591053241293288 Weiss, S. J., Nagle-Yang, S., Flynn, H., Cooper, B., Muzik, M., Simeonova, D. I., & Ozerdem, A. (2025). Gender differences in symptom profiles of individuals being treated for mood disorders. J Mood Anxiety Disord, 12, 100152. https://doi.org/10.1016/j.xjmad.2025.100152 West, M. L., Green, J., Barber, M. E., Sharif, S., Lisowski, V., & Friedman-Yakoobian, M. (2025). Overlap of obsessive compulsive and psychosis risk symptoms in a specialized clinic. Early Intervention in Psychiatry, 19(1), e13596. https://doi.org/10.1111/eip.13596 West, M. L., Pfluger, J., Sharif, S., Goods, C., & Friedman-Yakoobian, M. (2025). Enhancing Role Functioning in Clinical High Risk for Psychosis: An Open Trial of "InVEST" (Individualised Vocational and Educational Support and Training). Early Interv Psychiatry, 19(4), e70041. https://doi.org/10.1111/eip.70041 Winters, D. E., Spitz, J., Raymond, K., Natvig, C., Waller, R., Mikulich-Gilbertson, S. K., & Sakai, J. T. (2025). Affective theory of mind impairments linked with callous-unemotional traits implicate cognitive control: A pre-registered double-blind randomized controlled trial with a dual-task paradigm. J Affect Disord, 382, 417-427. https://doi.org/10.1016/j.jad.2025.04.154
Winters, D. E., Spitz, J., Raymond, K., Natvig, C., Waller, R., Mikulich-Gilbertson, S. K., Schacht, J. P., & Sakai, J. T. (2025). Cognitive Control Difficulties Differentiate Callous-Unemotional Traits from Conduct Problems: A Pre-Registered Double-Blind Randomized Controlled Trial Analysis. Child Psychiatry Hum Dev. https://doi.org/10.1007/s10578-025-01869-5 Wolfe, J. H., Lehto, S., Sakai, J. T., Mikulich-Gilbertson, S. K., & Davis, R. A. (2025). The impact of the COVID-19 pandemic on medical student mental health. PLOS Ment Health, 2(4), e0000264. https://doi.org/10.1371/journal.pmen.0000264 Wylie, K. P., & Tregellas, J. R. (2025). Rootlets Hierarchical Principal Component Analysis for Revealing Nested Dependencies in Hierarchical Data. Mathematics (Basel), 13(1). https://doi.org/10.3390/math13010072 Zhang, A. Z., Sehrt, M., Ley, S. A., Ross, K. V., Phimphasone-Brady, P., & McKenney, K. M. (2025). Gaps and opportunities in polycystic ovary syndrome care-a qualitative study. F S Rep, 6(3), 357-365. https://doi.org/10.1016/j.xfre.2025.05.011
2025 BOOK CHAPTERS Ariefdjohan, M., Nesi, J., Mullin, B., Pesko, M., & Fritsch, S. (2025). Youth Anxiety in the Digital Age: Present Status and Future Considerations. In D. A. Christakis & L. Hale (Eds.), Handbook of Children and Screens: Digital Media, Development, and Well-Being from Birth Through Adolescence (pp. 129136). Springer Nature Switzerland. https://doi.org/10.1007/978-3-031-69362-5_18 Boyd, B., Denu, Y., Zare, S., & Bowman, C. (2025). The health of Native Americans and Indigenous peoples. In APA handbook of health psychology, Volume 3: Health psychology and public health, Vol. 3 (pp. 237-256). American Psychological Association. https://doi.org/10.1037/0000396-013 Gatto, A. J. (2025). Screaming into the Void. In S. Harden (Ed.), (Re)search Yourself: How to Leverage Reflection and Vulnerability to Flourish in Academia and Beyond. Virginia Tech Publishing. https://doi.org/https://doi.org/10.21061/researchyourself. Glaze, K., Kelsay, K., & Talmi, A. (2025). Child & adolescent psychiatric disorders & psychosocial aspects of pediatrics. In W. W. Hay, M. J. Levin, M. Abzug, & M. Bunik (Eds.), Current Diagnosis and Treatment: Pediatrics (27 ed.). McGraw-Hill. Holland, M., & Hawks, J. (2025). Mindfulness and acceptance and commitment practices in the school setting: Practical interventions for children and adolescents (Trans. in Italian). Routledge.
Horen, N., Ash, J., & Fox, B. (2025). Getting Acquainted with infant and early childhood mental health consultation. In L. S. Nenide, K. Sweeney, G. Costa, N. M. Horen, & R. M. Corso (Eds.), Uniting Infant Mental Health and the Pyramid Model - Connecting Principals and Practices to Improve Outcomes. Brookes Publishing. Hilt, R., & Nussbaum A.M. (2025). DSM-5-TR Pocket Guide for Child and Adolescent Mental Health. Washington, D.C.: American Psychiatric Publishing 2025 ISBN: 9781615365462 Martinez, R., & Candilis, P. J. (2025). Robust Professionalism : Forensic Psychiatry’s Identity and Purpose. In W. C. Darby & R. Weinstock (Eds.), Forensic neuropsychiatric ethics: balancing competing duties in and out of court. American Psychiatric Association Publishing. Nussbaum, A. M. (2025). Review of Sant'Egidio's Dream: How a Catholic people's movement is meeting the challenge of AIDS in Africa and shaping the future of global health. Journal of Moral Theology, 14(2), 179-181. https://doi.org/https://doi.org/10.55476/001c.142759. Pugliese, C.E., Strang, J.F., Kenworthy, L., Cannon, L., Alexander, K., Werner, M., & Anthony, L.G. (In press). Unstuck and On Target! Ages 14-22: An Executive Function Curriculum to Support Flexibility, Planning, and Organization. Baltimore: Paul H. Brookes Publishing Co., Inc. Riggs, P. (2025). Life of the Party, Chapter 7. In C. A. Galanter & P. S. Jensen (Eds.), DSM-5-TR Casebook and Treatment Guide for Child Mental Health. American Psychiatric Association Publishing. Safer-Lichtenstein, J., Alexander, K., Adler Warner, M., & Ratto, A. B. (2025). Executive Function Intervention: The “Unstuck and On Target!” Program. In R. E. Oliveras-Rentas, M. Vega-Carrero, & W. Rodriguez-Irizarry (Eds.), El Espectro del Autismo: Manual Clínico para la Identificación y la Intervención. Manual Moderno. Seagly, K., Waldron-Perrine, B., Mattes, A., Chao, D., Ellois, V., Noyes, E., & Johnson, A. (2025). Assessment in rehabilitation psychology. In M. A. Meade, K. T. Bechtold, & S. T. Wegener (Eds.), The Oxford handbook of rehabilitation psychology (2 ed.). Oxford University Press. Torres, J., Kuperman, K., & Wolf, J. (2025). Assessing Social, Emotional, and Behavioral Functioning in Emergent Bilingual Youth. In D. Vega & J. Wolf (Eds.), Culturally and Linguistically Responsive Intervention and Assessment Practices with Emergent Bilingual Students (pp. 187-203). Springer Nature.
THANKS FOR READING We greatly appreciate your continued support of the Department of Psychiatry in our efforts to promote brain health for all, for life.
If you wish to contribute financially to our mission, we would be forever grateful for your gift. Please reach out to our Advancement Representative for whom contact info is listed below.
Kyle Smith Anschutz Advancement kyle.jaccaudsmith@cuanschutz.edu
HOLIDAY PARTY 2025
CANNABIS RESEARCH POSTER SESSION
COALITION OF ATHLETIC COMMUNITIES FOR MENTAL HEALTH
POSTER SESSION
EXPOSUREPALOOZA
LOVE, ANYTHING
ART EXHIBIT AND SPEAKER SERIES
BLOCK PARTY 2026
APPRECIATION EVENTS
HARRIS 30TH ANNIVERSARY EVENT
PSYCHIATRY UNDERGRADUATE RESEARCH PROGRAM AND LEARNING EXPERIENCE (PURPLE)